norethindrone has been researched along with medroxyprogesterone acetate in 317 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 85 (26.81) | 18.7374 |
| 1990's | 73 (23.03) | 18.2507 |
| 2000's | 89 (28.08) | 29.6817 |
| 2010's | 62 (19.56) | 24.3611 |
| 2020's | 8 (2.52) | 2.80 |
| Authors | Studies |
|---|---|
| Kollman, PA; Lee, DL; Marsh, FJ; Wolff, ME | 1 |
| Edwards, JP; Gottardis, MM; Jones, TK; Mais, DE; Marschke, KB; West, SJ | 1 |
| Ernst, B; Lill, MA; Vedani, A; Winiger, F | 1 |
| Ban, F; Cherkasov, A; Fallahi, M; Hammond, GL; Santos-Filho, O; Thorsteinson, N | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Diamant, YZ; Kleinman, Y; Livshin, Y; Reisin, A; Tadmor, OP | 1 |
| Cullins, VE | 1 |
| Fraser, DI; Hillard, TC; Pryse-Davies, J; Siddle, NC; Whitehead, MI | 1 |
| Judd, HL | 1 |
| Crona, N; Enk, L; Landgren, BM; Lindberg, UB; Silfverstolpe, G | 1 |
| Keisler, LW; Kier, AB; Walker, SE | 1 |
| Edgren, RA | 1 |
| Cassidenti, DL; Lobo, RA; Paulson, RJ; Serafini, P; Stanczyk, FZ | 1 |
| Koetsawang, S | 2 |
| Jeng, MH; Jordan, VC | 1 |
| Shaaban, MM | 1 |
| Abdel-Razik, M; al-Azzony, M; al-Kholy, G; Fahmy, K; Saad, S; Shaaraway, M; Wagdi, A | 1 |
| Kuhl, H; Pietzsch, V | 1 |
| Sapire, KE | 1 |
| LaRosa, JC; Miller, VT; Muesing, RA; Phillips, EA; Stillman, RJ; Stoy, DB | 1 |
| Meyer, JE; Ravnikar, VA; Stomper, PC; Van Voorhis, BJ | 1 |
| Barbieri, RL | 1 |
| Bretin, H; Herschkorn, P; Lasselain, J; Thebaud-Mony, A | 1 |
| Artini, P; Coukos, G; Genazzani, AD; Genazzani, AR; Lattesa, AM; Nappi, C; Petraglia, F; Silferi, M; Volpe, A | 1 |
| Levin, JH; Lobo, RA; Tonetta, SA | 1 |
| Fraser, IS | 4 |
| Shubik, P | 1 |
| Kitawaki, J; Okada, H; Yamamoto, T | 1 |
| Alba, VM; Alvarado, G; Bassol, S; Cravioto, MC; Garza-Flores, J; Hernandez, L; Perez-Palacios, G; Recio, R; Rivera, R | 1 |
| Kitawaki, J; Okada, H; Shiroshita, K; Yamamoto, T | 1 |
| Kaunitz, AM | 2 |
| Kazi, AI | 1 |
| Dören, M; Montag, M; Schneider, HP | 1 |
| Fujimoto, J; Fujita, H; Hosoda, S; Okada, H | 1 |
| Florio, V; Morini, A; Mossa, B; Roscetti, C | 1 |
| Mishell, DR | 1 |
| Abdel-Sayed, WS; Darwish, EA; el-Habashy, MA; Haiba, NA; Nayel, SE; Said, SA | 1 |
| Amatayakul, K; Suriyanon, V | 1 |
| Carpenter, JT | 1 |
| Mazella, J; Sun, B; Tseng, L | 1 |
| Keller, PJ | 1 |
| Bhowmik, T; Mukherjea, M | 2 |
| Fotherby, K | 1 |
| King, RJ; Whitehead, MI | 1 |
| Griesinger, R; Schindler, AE | 1 |
| Odlind, V | 1 |
| Chinvanthannond, P; Samransamruajkit, S | 1 |
| el-Faras, A; el-Sibai, FA; Ismail, AA; Rocca, M; Toppozada, M | 1 |
| Bloch, E; Varma, SK | 1 |
| Fujimoto, J; Fujita, H; Nakata, Y; Okada, H | 1 |
| Rabe, T; Runnebaum, B | 1 |
| Okada, H | 1 |
| Amatayakul, K; Petpoo, W; Ratanawananukul, N; Suriyanon, V; Tanthayaphinant, O; Tovanabutra, S | 1 |
| Guerin, JF; Rollet, J | 1 |
| Belsey, EM | 1 |
| Bergamaschi, M; Facchinetti, F; Genazzani, AD; Genazzani, AR; Petraglia, F; Volpe, A | 1 |
| Wilson, E | 1 |
| Aly, MY; Fathalla, MF; Salah, M; Salem, HT; Shaaban, MM; Thabet, AI | 1 |
| Boyd, ME | 1 |
| Anderson, J; Cravioto, MC; del Real Mora, O; Díaz Sánchez, V; Garza-Flores, J; Landeros, J; Lichtenberg, R; Pérez-Palacios, G; Rodríguez, V | 1 |
| Cardenas, S; Cravioto, MC; Diaz-Sanchez, V; Garza-Flores, J; Perez-Palacios, G; Rodríguez, V | 1 |
| von Schoultz, B | 1 |
| Aedo, AR; Diczfalusy, E; Johannisson, E; Landgren, BM | 1 |
| Das, S; Datta, SC; Dey, S; Guin, AK; Sengupta, D | 1 |
| Conti, G; Di Carlo, F; Gallo, E; Racca, S | 1 |
| Fotherby, K; Koetsawang, S; Mangalam, M; Nukulkarn, P; Shrimanker, K; Towobola, K | 1 |
| Benagiano, G; Primiero, FM | 1 |
| Birke, LI; Holzhausen, C; Murphy, S | 1 |
| Adlercreutz, H; Hämäläinen, EK; Korpela, JT; Pulkkinen, MO | 1 |
| Elder, MG | 1 |
| Correu Azcona, S; Velasco Murillo, V | 1 |
| Flowers, CE; Hyde, BM; Wilborn, WH | 1 |
| Burket, RL; Rauh, JL; Waldrop, CD | 1 |
| Babu, S; Prema, K; Ramalakshmi, BA | 1 |
| Castaneda, TA; Gambrell, RD; Massey, FM; Ricci, CA; Ugenas, AJ; Wright, JM | 1 |
| Jahan, FA; Khan, AR; Swenson, I | 1 |
| Das, S; Datta, SC; Guin, AK; Sengupta, D | 1 |
| Fraser, IS; Weisberg, E | 1 |
| Fernández-Aparicio, MA; Medina, M; Pérez-Palacios, G; Ulloa-Aguirre, A; Zacarías-Villareal, J | 1 |
| Arntzenius, AC; Havekes, L; Hessel, LW; Stegerhoek, CI; van Gent, CM | 1 |
| Gustafson, A; Samsioe, G; Silfverstolpe, G; Svanborg, A | 1 |
| Chávez, B; Escobar, N; Larrea, F; Lince, M; Pérez, AE; Pérez-Palacios, G; Vilchis, F | 1 |
| Dören, M; Minne, HW; Reuther, G; Schneider, HP | 1 |
| Taskinen, MR | 1 |
| Paskowitz, RA | 1 |
| Hales, HA; Hatasaka, HH; Jones, KP; Mainwaring, R; Peterson, CM; Poulson, AM; Stevenson, K | 1 |
| Datey, S; Gaur, LN; Saxena, BN | 1 |
| Chen, JK; Chen, SF; Fang, KJ; Ge, JL; Ge, RS; He, ML; Luo, SY; Sang, GW; Shao, QX; Song, S | 2 |
| Bassol, S; Hernandez, C; Luz de la Cruz, D; Nava, MP; Trujillo, AM | 1 |
| Haverkorn, MJ; Meuwissen, JH; Wiegerinck, MA | 1 |
| Christiansen, C; Marslew, U; Munk-Nielsen, N; Nilas, L; Riis, BJ | 1 |
| Barbuto, DA; Judd, HL; Karlan, BY; Lagasse, LD; Leuchter, RS; McGonigle, KF | 1 |
| Toppozada, MK | 1 |
| Sang, GW | 1 |
| Giwa-Osagie, OF | 1 |
| el-Hussein, M; el-Nahal, N; Hassan, EO | 1 |
| d'Arcangues, C | 2 |
| Kekkonen, R; Lähteenmäki, P; Luukkainen, T; Tuominen, J | 1 |
| Boyd, ME; Colgan, TJ; Ferenczy, A; Fugere, P; Lorrain, J; Ross, AH | 1 |
| Joosten, JW; Kloosterboer, HJ; Schoonen, WG | 2 |
| Dommisse, J; Sapire, KE | 1 |
| Bjäörn, M; Ehnholm, C; Kääriänen, J; Lahdenperä, S; Luotola, H; Puolakka, J; Pyörälä, T; Taskinen, MR | 1 |
| Dören, M; Schneider, HP | 1 |
| Edmonds, DK | 1 |
| Kahri, J; Lahdenperä, S; Lappi, M; Luotola, H; Puolakka, J; Pyörälä, T; Taskinen, MR; Tilly-Kiesi, M | 1 |
| Mc Eneny, J; Mc Manus, J; Thompson, W; Young, IS | 1 |
| Altamirano, L; Canales, JR; De Aguilar, MA; De Fung, RC; Gonzalez, JD; Grillo, AE; Leon, DA; Pozuelos, JL; Ramirez, L; Rigionni, R; Salgado, JS; Sanchez, Jdel C; Torres, L; Vallecillos, G; Zambrano, EJ; Zea, C | 1 |
| Hyder, SM; Murthy, L; Stancel, GM | 1 |
| Arteaga, A; Arteaga, E; Bianchi, M; Durán, D; Rojas, A; Villaseca, P | 1 |
| Felix, JC; Moyer, DL | 1 |
| Lippert, TH; Mueck, AO; Seeger, H | 1 |
| Dakin, L; Rowlands, SC | 1 |
| Hampton, AL; Nie, G; Salamonsen, LA | 1 |
| el Houssinie, M; el Nahal, N; Hassan, EO | 1 |
| el-Hussinie, M; el-Nahal, N; Hassan, EO | 1 |
| Cromie, MA; Garceau, RJ; Kaunitz, AM | 1 |
| Oleen-Burkey, M; Shulman, LP; Willke, RJ | 1 |
| Cromie, MA; Maile, MH; Wajszczuk, CP | 1 |
| Gibson, JM; Heald, A; Selby, PL; White, A | 1 |
| Bäckström, T; Bixo, M; Björn, I; Nöjd, KS; Nyberg, S | 1 |
| Garceau, RJ; Kaunitz, AM; Wajszczuk, CJ | 1 |
| Bäckström, T; Jonsson, B; Odmark, IS | 1 |
| Gray, A; McFadyen, L; Smit, J; Zuma, K | 1 |
| Bäckström, T; Nyberg, S; Sundström-Poromaa, I; Wihlbäck, AC | 1 |
| Bilgen, I; Bilgin, O; Coşan Terek, M; Memiş, A; Ozşener, S; Oztekin, K; Sendağ, F | 1 |
| Altare, F; Buzio, C; Campagnoli, C; Sanseverino, P | 1 |
| Berenson, AB; Grady, JJ; Radecki, CM; Rickert, VI; Thomas, A | 1 |
| Bruhat, M; Kainulainen, P; Rudolf, K; Timonen, U; Vaheri, R; Viitanen, A | 1 |
| Bilgin, O; Karadadaş, N; Sendağ, F; Terek, MC | 1 |
| Lippert, C; Mueck, AO; Seeger, H; Wallwiener, D | 1 |
| Beksinska, ME; Rees, HV; Smit, J | 1 |
| Graff-Iversen, S; Tonstad, S | 1 |
| Honjo, H; Hosoda, T; Kitawaki, J; Tanaka, K; Tatsumi, H | 1 |
| Applezweig, N | 1 |
| Zanartu, J | 1 |
| Gordon, M; Hemperly, S; Kohorn, EI; Rice, SI | 1 |
| Ammar, R; El-mahgoub, S; Karim, M; Yassin, S | 1 |
| Hahn, DW; Mcguire, JL; Philipps, A | 1 |
| Olsson, SE | 1 |
| Finger, WR | 1 |
| McFadyen, L; Preston-Whyte, E; Smit, J; Zuma, K | 1 |
| El-mahgoub, S; Karim, M | 1 |
| Fotherby, K; Howard, G | 1 |
| Abdel-sayed, WS; El-sayed, OK; Said, SA; Toppozada, HK | 1 |
| Kistner, RW | 1 |
| Beck, P; Hoff, DL; Venable, RL | 1 |
| Prous, JR; Sussmann, AR | 1 |
| Fekete, G | 1 |
| Rozenbaum, H | 1 |
| El-sokkary, H; Nayel, S; Toppozada, M; Tork, M | 1 |
| Molitor-peffer, MP | 1 |
| Rutter, T | 1 |
| Andersen, LF; Bladbjerg, EM; Jespersen, J; Skouby, SO | 1 |
| Beksinska, ME; Rees, HV | 1 |
| Liu, JH; Shumel, BS; Simon, JA; Speroff, L; Symons, JP | 1 |
| Mueck, AO; Seeger, H; Wallwiener, D | 4 |
| Anthony, MS; Cline, JM; Fox, JL; Suparto, IH; Williams, JK | 1 |
| Lynge, E; Ottesen, B; Pederson, AT; Stahlberg, C | 1 |
| Boubli, L; Carpentier-Meunier, S; Charpin, C; Dales, JP; Garcia, S; Illouz, S; Lavaut, MN; Sferlazzo, K | 1 |
| D'INCERTI BONINI, L; PAGANI, C | 1 |
| Aktepe, O; Altindis, M; Fenkci, S; Fenkci, V; Kurtay, G; Sonmezer, M; Yilmazer, M | 1 |
| Atabekoglu, C; Cengiz, B; Cengiz, SD; Cetinkaya, E | 1 |
| Beksinska, ME; Farley, TM; Guidozzi, F; Kleinschmidt, I; Rees, HV; Smit, JA | 1 |
| Archer, DF; Leslie, S; Mirkin, S; Navarro, FJ | 1 |
| Bassol, S; Canto de Cetina, TE; Cetina Canto, JA; Luna, MO | 1 |
| Ho, KK; Leung, KC; Nugent, AG; Reutens, AT; Sullivan, D | 1 |
| Clark, L; Garces, A; Rhodin, J; Thomas, T | 1 |
| Berenson, AB; Breitkopf, CR; Grady, JJ; Rickert, VI; Thomas, A | 1 |
| Bäckström, T; Bixo, M; Haeger, M; Jonsson, B; Odmark, IS | 1 |
| Dalsgaard, T; Lund, CO; Nilas, L; Ottesen, B; Pedersen, NG; Pedersen, SH | 2 |
| Engelstein, M; Kuhl, H; Mäenpää, J; Mattila, L; Mustonen, M; Rees, MC | 1 |
| Heikkinen, J; Mäenpää, J; Mattsson, LA; Skouby, SO; Timonen, U; Vaheri, R | 1 |
| Bäckström, T; Bixo, M; Jonsson, B; Odmark, IS | 2 |
| Alessandrini, C; Arangino, S; Baldassari, F; Cagnacci, A; Landi, S; Volpe, A | 1 |
| Christodoulakos, GE; Creatsas, GC; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Papadias, CA | 1 |
| Bäckström, T; Dahmoun, M; Karlsson, MG; Odmark, IS; Pavlenko, T; Risberg, B | 1 |
| Beckman, M | 1 |
| Athayde, C; Coutinho, EM; Maia, H; Maltez, A; Studard, E | 1 |
| Beksinska, ME; Farley, TM; Kleinschmidt, I; Mbatha, F; Smit, JA | 1 |
| Botsis, D; Caramalis, G; Christodoulakos, G; Creatsas, G; Lambrinoudaki, I; Panoulis, C; Rizos, D; Sioulas, V | 1 |
| Fushiki, S; Hirasugi, Y; Honjo, H; Hosoda, T; Iwasa, K; Kawata, M; Kikuchi, N; Kitawaki, J; Mihara, M; Oida, N; Tatsumi, H; Yamamoto, H | 1 |
| Cline, JM; Cosman, F; Gardner, TR; Lindsay, R; Mikhail, MS; Preiss-Bloom, AO; Scotti, RJ; Vardy, MD; Williams, JK | 1 |
| Gursel, T; Gursoy, R; Himmetoglu, O; Karabulut, E; Onan, MA; Ozpolat, E; Taner, MZ; Taskiran, C | 1 |
| Fox, JL; Koudy Williams, J; Suparto, IH; Vinten-Johansen, J | 1 |
| Bernardi, F; Casarosa, E; Gabbanini, M; Genazzani, AD; Genazzani, AR; Luisi, M; Palumbo, M; Picciarelli, G; Pieri, M; Pluchino, N | 1 |
| Anderson, S; Durrington, PN; Gibson, MJ; Heald, A; Kaushal, K; Redpath, M; Selby, PL | 1 |
| Hapgood, JP; Koubovec, D; Louw, A; Ronacher, K; Stubsrud, E | 1 |
| Mueck, AO; Rakov, V; Seeger, H | 1 |
| Andersen, TO; Eilertsen, AL; Høibraaten, E; Os, I; Sandset, PM; Sandvik, L | 1 |
| Botsis, D; Christodoulakos, GE; Creatsa, M; Lambrinoudaki, IV; Panoulis, KP; Vlachou, S; Vourtsi, AD | 1 |
| Affandi, B | 1 |
| Eren, S; Pekin, O; Tugrul, S; Uslu, H; Yildirim, G | 1 |
| Franke, HR; Vermes, I; Werner, HM | 1 |
| Bacon, J; Breech, L; Quint, EH; Schwandt, A | 1 |
| Shittu, O; Sule, S | 1 |
| Hoffman, M; Morroni, C; Moss, M; Myer, L | 1 |
| Beksinska, M; Draper, BH; Hapgood, J; Hoffman, M; Morroni, C; Smit, J; Van der Merwe, L | 1 |
| Bahamondes, L; dos Santos Fernandes, AM; Juliato, CT; Simões, JA; Sobreira-Lima, B; Villarreal, M | 1 |
| Aberg, J; Aweeka, FT; Bardeguez, A; Coombs, RW; Lizak, P; Rosenkranz, SL; Segal, Y; Thevanayagam, L; Watts, DH | 1 |
| Eren, S; Kutlu, T; Pekin, O; Tugrul, S; Uslu, H; Yildirim, G | 1 |
| Denny, L; Kuhn, L; Myer, L; Wright, TC | 1 |
| Abdallah, MA; Abdullah, HI; Gercel-Taylor, C; Kang, S; Nakajima, ST; Taylor, DD | 1 |
| Godoy-Tundidor, S; Ho, SM; Mukherjee, K; Syed, V | 1 |
| Demircan, S; Kizilkaya, K; Köseoğlu, K; Odabasi, AR; Onur, E; Yüksel, H | 1 |
| Beksinska, ME; Farley, TM; Kleinschmidt, I; Smit, JA | 3 |
| Kloosterboer, HJ; Mueck, AO; Seeger, H; Studen, M; Wallwiener, D | 1 |
| Alexandrou, AP; Bastounis, E; Bramis, J; Christodoulakos, GE; Creatsas, GC; Dalamanga, A; Keramaris, NC; Lambrinoudaki, IV | 1 |
| Darney, PD; Haider, S | 1 |
| Constant, D; Cooper, D; Hoffman, M; Kalla, AA; Micklesfield, L; Rosenberg, L; Zhang, Y | 1 |
| Baskan, B; Demir, B; Haberal, A; Kandemir, O; Karabulut, E; Ozturkoglu, E; Solaroglu, A | 1 |
| Berkman, S; Ceyhan, A; Evlioglu, G; Issever, H; Keskin, H; Nekora-Azak, A | 1 |
| Fournier, A; Weiderpass, E | 1 |
| Beksinska, ME; Farley, TM; Kleinschmidt, I; Rees, HV; Smit, JA | 1 |
| Curtis, KM; Paulen, ME | 1 |
| Atashili, J; Delany, S; Kleinschmidt, I; Miller, WC; Pettifor, A; Rees, H | 1 |
| Beksinska, ME; Farley, TM; Kleinschmidt, I; Milford, C; Smit, JA | 1 |
| Balogun, OR; Raji, HO | 1 |
| Freeman, S; Shulman, LP | 1 |
| Jespersen, J; Schwarz, H; Sidelmann, JJ; Skouby, SO; Vitzthum, F | 1 |
| Weisberg, E | 1 |
| Akgul, MA; Bozkurt, U; Haberal, A; Kayikcioglu, F; Ozdegirmenci, O | 1 |
| Nieschlag, E | 1 |
| Africander, D; Hapgood, JP; Louw, R; Noeth, D; Verhoog, N | 1 |
| Ahmed, K; Chen, PL; Friedland, B; Gehret-Plagianos, M; Kwok, C; Lahteenmaki, P; Morrison, CS; Patel, S; Ramjee, G; Skoler-Karpoff, S; van de Wijgert, J | 1 |
| Cahill, MA; Fehm, T; Mueck, AO; Neubauer, H; Ruan, X; Schneck, H; Schultz, S; Seeger, H; Yang, Y | 1 |
| Koskela-Niska, V; Lyytinen, H; Pukkala, E; Riska, A; Ylikorkala, O | 1 |
| Cahill, MA; Fehm, T; Mueck, AO; Neubauer, H; Ruan, X; Schneck, H; Seeger, H | 1 |
| Cannegieter, SC; Helmerhorst, FM; Lijfering, WM; Roach, RE; Rosendaal, FR; van Hylckama Vlieg, A | 1 |
| Africander, D; Hapgood, JP; Louw, R | 1 |
| Cahill, MA; Fehm, T; Hyder, SM; Liang, Y; Mafuvadze, B; Mueck, AO; Neubauer, H; Ruan, X; Schneck, H; Seeger, H | 1 |
| Avenant, C; Du Toit, A; Hapgood, JP; Ray, RM; Tomasicchio, M | 1 |
| Hallett, T; McCoy, SI; Padian, N; Ralph, LJ | 1 |
| Cahill, MA; Chen, R; Fehm, T; Mueck, AO; Neubauer, H; Seeger, H; Yu, Q; Zhou, J | 1 |
| Abass, MM; Abdul-Hadi, RA; Aiyenigba, BO; Chabikuli, ON; Hamelmann, C; Ibrahim, MD; Ladipo, OA; Odafe, S; Oseni, LO | 1 |
| Chen, FP; Chen, HY; Chien, MH; Huang, TS; Ng, YT | 1 |
| Cates, W | 1 |
| Gollub, EL; Stein, Z | 1 |
| Redd, AD | 1 |
| Hallett, T; McCoy, S; Padian, N; Ralph, L | 1 |
| Avenant, C; Govender, Y; Hapgood, JP; Ray, RM; Tomasicchio, M | 1 |
| Hel, Z; Huijbregts, RP; Michel, KG | 1 |
| Cooney, R; Hayward, P | 1 |
| Africander, D; Avenant, C; Govender, Y; Grantham, NJ; Hapgood, JP; Ray, RM; Verhoog, NJ | 1 |
| Africander, DJ; Hapgood, JP; Storbeck, KH | 1 |
| Deenen, R; Fischer, JW; Freudenberger, T; Heim, HK; Köhrer, K; Kretschmer, I; Mayer, P; Seiler, LF; Zimmermann, A | 1 |
| Blanchard, K; Chipato, T; Harper, CC; Nhemachena, T; Ramjee, G | 1 |
| Curtis, KM; Hannaford, P; Phillips, SJ; Polis, CB; Raymond, E; Steyn, PS; Turner, AN; Westreich, DJ | 1 |
| Fan, P; Jordan, VC; Sweeney, EE | 1 |
| Cunha, EP; Fernandes, CE; Mader, AM; Pinhal, MA; Pompei, LM; Silva, VF; Silveira, ER; Steiner, ML; Theodoro, TR | 1 |
| Baeten, JM; Brown, J; Chen, PL; Crook, AM; Delany-Moretlwe, S; Francis, SC; Friedland, BA; Hayes, RJ; Heffron, R; Kapiga, S; Karim, QA; Karpoff, S; Kaul, R; Kwok, C; Low, N; McClelland, RS; McCormack, S; McGrath, N; Morrison, CS; Myer, L; Rees, H; Stalter, R; Van Damme, L; van de Wijgert, JH; van der Straten, A; Watson-Jones, D | 1 |
| Cunha, EP; Fernandes, CE; Mader, AM; Petri, G; Pinhal, MA; Pompei, LM; Steiner, ML; Theodoro, TR | 1 |
| Baeten, JM; Balkus, JE; Bunge, K; Chirenje, ZM; Gomez, K; Hillier, SL; Marrazzo, JM; Nair, G; Noguchi, LM; Palanee-Phillips, T; Parikh, UM; Piper, JM; Ramjee, G; Richardson, BA; Selepe, P; van der Straten, A; Watts, DH | 1 |
| Abdellati, S; Agot, K; Ahmed, K; Cohen, M; Crucitti, T; Deese, J; Masson, L; Miller, W; Morrison, C; Van Damme, L; Wang, M | 1 |
| Callahan, R; Halpern, V; Nanda, K; Yacobson, I | 1 |
| Jones, HE; van de Wijgert, JH | 2 |
| Averbach, S; Darney, P; Seidman, D; Smith-McCune, K | 1 |
| Hofmeyr, GJ; Lawrie, TA; Singata, M; Temmerman, M | 1 |
| Balkus, JE; Marrazzo, JM; Noguchi, LM; Richardson, BA | 1 |
| Schooling, CM | 1 |
| Gollub, EL; Jones, HE; Ralph, LJ | 1 |
| Abdel-Raouf, SM; Abdeldayem, HM; Arafa, EM; Atwa, K; Girbash, EF; Nooh, AM | 1 |
| Bergendal, A; Hirschberg, AL; Kieler, H; Kocoska-Maras, L; Sundström, A | 1 |
| Bergel, E; Hofmeyr, GJ; Lawrie, TA; Singata-Madliki, M; Temmerman, M | 1 |
| Acosta, JI; Andrews, MG; Bimonte-Nelson, HA; Braden, BB; Lavery, C; Mennenga, SE | 1 |
| Bersinger, N; Cagnacci, A; Grandi, G; McKinnon, B; Mueller, M; Nirgianakis, K; Papadia, A | 1 |
| Dorflinger, L; Halpern, V; Schivone, G | 1 |
| Bersinger, NA; Facchinetti, F; Grandi, G; McKinnon, BD; Mueller, MD | 1 |
| Baeten, JM; Balkus, JE; Brown, ER; Chappell, C; Harkoo, I; Jeenarain, N; Kabwigu, S; Kintu, K; Kiweewa, FM; Marzinke, M; Naidoo, L; Nair, G; Nakabiito, C; Palanee-Phillips, T; Reddy, K; Siva, S; Soto-Torres, L | 1 |
| Achilles, SL; Austin, MN; Chirenje, ZM; Hillier, SL; Meyn, LA; Mhlanga, F | 1 |
| Barra, F; Ferrero, S; Scala, C | 1 |
| Avenant, C; Bick, AJ; Govender, Y; Hapgood, JP; Maritz, MF; Ray, RM; Tomasicchio, M; Woodland, JG | 1 |
| Achilles, SL; Dorflinger, LJ; Hapgood, JP; Heffron, R; Kiarie, J; Polis, CB; Steyn, PS | 1 |
| Avenant, C; Dlamini, S; Hapgood, JP; Maritz, MF; Ray, RM; Tomasicchio, M; van der Spuy, Z | 1 |
| Achilles, SL; Chirenje, ZM; Hillier, SL; Maramba, A; Matubu, A; Mbizvo, M; Meyn, LA; Mhlanga, F; Stoner, KA | 1 |
| Aceves, KM; Cherpes, TL; Gabriel, JM; Hatfield, AM; Kaur, B; Kwiek, JJ; Quispe Calla, NE; Torres, AR; Trout, W; Vicetti Miguel, RD | 1 |
| Achilles, SL; Chirenje, ZM; Hillier, SL; Maramba, A; Matubu, AT; Mbizvo, M; Meyn, LA; Mhlanga, F; Stoner, KA | 1 |
| Patel, MV; Rodriguez-Garcia, M; Shen, Z; Wira, CR | 1 |
| Baeten, JM; Balle, C; Bekker, LG; Brown, BP; Bunjun, R; Dabee, S; Feng, C; Gill, K; Happel, AU; Heffron, R; Jaspan, HB; Jaumdally, SZ; Konstantinus, IN; Nair, G; Onono, M; Palanee-Phillips, T; Passmore, JS; Tanko, RF | 1 |
| Africander, DJ; Avenant, C; Hapgood, JP; Komane, M; Louw-du Toit, R | 1 |
| Cockrum, RH; Cohen, KS; Ham, SA; Snow, SG; Soo, J | 1 |
| Africander, D; Jackson, H; Louw-du Toit, R; Perkins, MS; Simons, M | 1 |
30 review(s) available for norethindrone and medroxyprogesterone acetate
| Article | Year |
|---|---|
Injectable and implantable contraceptives.
Topics: Capsules; Contraceptive Agents, Female; Drug Implants; Humans; Injections; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Microspheres; Norethindrone | 1992 |
Gonadotropin-releasing hormone agonists: strategies for managing the hypoestrogenic effects of therapy.
Topics: Bone Density; Climacteric; Drug Therapy, Combination; Endometriosis; Estrogens; Female; Fertility; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Progestins | 1992 |
Oral contraception: a review.
Topics: Contraceptives, Oral; Ethynodiol Diacetate; Female; History, 20th Century; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethynodrel; Norgestrel; Progesterone; United States; United States Food and Drug Administration | 1991 |
The injectable contraceptive: present and future trends.
Topics: Contraception; Contraceptive Agents, Female; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone | 1991 |
Injectable contraception.
Topics: Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone | 1989 |
Progestational agents in the treatment of breast cancer.
Topics: Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Norethindrone; Norethindrone Acetate; Progestins | 1988 |
[Hormonal contraception using depot preparations].
Topics: Abnormalities, Drug-Induced; Blood Coagulation; Carbohydrate Metabolism; Cardiovascular Diseases; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Levonorgestrel; Liver; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Pregnancy; Risk | 1986 |
New delivery systems for hormonal contraception.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Pregnancy; Progesterone; Progestins; Research; Time Factors; Vagina | 1986 |
Long acting contraceptives. Present status.
Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Drug Combinations; Drug Implants; Estradiol Congeners; Female; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Progestins | 1983 |
Long acting injectable hormonal contraceptives.
Topics: Animals; Breast Neoplasms; Contraceptive Agents; Delayed-Action Preparations; Dogs; Drug Administration Schedule; Female; Fetus; Humans; Infertility, Female; Infusions, Parenteral; Lactation; Macaca mulatta; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone; Norethindrone Acetate; Pregnancy; Time Factors; Uterine Neoplasms | 1982 |
A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate.
Topics: Australia; Blood Pressure; Breast Neoplasms; Contraceptives, Oral; Drug Implants; Female; Fertility; Fetus; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; Thrombophlebitis; Uterine Cervical Neoplasms | 1981 |
Existing once-a-month combined injectable contraceptives.
Topics: Algestone Acetophenide; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone | 1994 |
Pharmacodynamic effects of once-a-month combined injectable contraceptives.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; China; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Latin America; Medroxyprogesterone Acetate; Norethindrone | 1994 |
Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; Clinical Trials, Phase III as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Multicenter Studies as Topic; Norethindrone; Randomized Controlled Trials as Topic | 1994 |
Metabolic effects of once-a-month combined injectable contraceptives. The World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation, Geneva, Switzerland.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; Carbohydrate Metabolism; Contraceptive Agents, Female; Estradiol; Female; Hemostasis; Humans; Hydroxyprogesterones; Injections; Lipid Metabolism; Medroxyprogesterone Acetate; Norethindrone | 1994 |
Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Animals; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Drug Evaluation; Estradiol; Estrogen Antagonists; Estrogens, Conjugated (USP); Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; World Health Organization | 1993 |
Current status of injectable hormonal contraception, with special reference to the monthly method.
Topics: Contraceptive Agents, Female; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Pregnancy | 1997 |
Hormone replacement therapy and risk of breast cancer: the role of progestins.
Topics: Breast Neoplasms; Drug Administration Schedule; Epidemiologic Studies; Estrogen Replacement Therapy; Europe; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Meta-Analysis as Topic; Middle Aged; Norethindrone; Norethindrone Acetate; Progestins; Risk Factors; United States | 2003 |
Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception.
Topics: Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic | 2006 |
Injectable contraception.
Topics: Abdominal Pain; Anxiety; Contraceptive Agents, Female; Dizziness; Estradiol; Female; Headache; Humans; Injections; Medroxyprogesterone Acetate; Norethindrone; Patient Satisfaction; Safety; Weight Gain | 2007 |
When can a woman have repeat progestogen-only injectables--depot medroxyprogesterone acetate or norethisterone enantate?
Topics: Female; Fertility; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; Ovulation; Pregnancy | 2009 |
Considerations for the use of progestin-only contraceptives.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Counseling; Desogestrel; Drug Prescriptions; Family Planning Services; Female; Health Promotion; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Patient Education as Topic; Patient Selection; Pregnancy, Unplanned; Progesterone Congeners; Risk Factors; United States | 2010 |
The struggle for male hormonal contraception.
Topics: Azoospermia; Clinical Trials as Topic; Contraception; Contraceptive Agents, Male; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Pregnancy Rate; Progesterone Congeners; Progestins; Testosterone | 2011 |
Differential glucocorticoid receptor-mediated effects on immunomodulatory gene expression by progestin contraceptives: implications for HIV-1 pathogenesis.
Topics: Africa South of the Sahara; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Female; HIV Infections; HIV-1; Humans; Immunosuppression Therapy; Medroxyprogesterone Acetate; Norethindrone; Progesterone Congeners; Receptors, Glucocorticoid | 2014 |
Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence.
Topics: Administration, Oral; Africa; Condoms; Contraceptive Agents, Female; Female; HIV Infections; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone | 2014 |
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.
Topics: Adolescent; Adult; Africa South of the Sahara; Contraceptive Agents, Female; Female; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Risk Factors | 2015 |
Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: a systematic review.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Incidence; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Pregnancy, Ectopic; Progestins | 2015 |
Hormonal contraceptive use and women's risk of HIV acquisition: priorities emerging from recent data.
Topics: Adult; Contraceptive Agents, Female; Female; Health Knowledge, Attitudes, Practice; Health Priorities; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Norethindrone; Public Health; Risk Assessment; Risk Factors; Sexual Behavior | 2015 |
Injectable contraception: updates and innovation.
Topics: Abortion, Induced; Adult; Contraception; Contraceptive Agents, Female; Drug Delivery Systems; Family Planning Services; Female; Health Services Accessibility; HIV Infections; Humans; Injections; Medroxyprogesterone Acetate; Norethindrone; Patient Compliance; Pregnancy; Pregnancy, Unplanned; Risk | 2016 |
Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis.
Topics: Administration, Oral; Endometriosis; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Pelvic Pain; Progestins; Randomized Controlled Trials as Topic; Receptors, Steroid | 2018 |
79 trial(s) available for norethindrone and medroxyprogesterone acetate
| Article | Year |
|---|---|
Contraception with progestogens and progesterone during lactation.
Topics: Contraceptive Devices, Female; Humans; Infant Nutritional Physiological Phenomena; Infant, Newborn; Lactation; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norethindrone; Progesterone; Psychophysiology | 1991 |
Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile.
Topics: Blood Glucose; Carbohydrate Metabolism; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Female; Growth Hormone; Humans; Hydrocortisone; Insulin; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pyruvates; Radioimmunoassay; Time Factors | 1991 |
A study of bleeding patterns with two injectable contraceptives given postpartum and the effect of two non-hormonal treatments.
Topics: Contraceptive Agents, Female; Double-Blind Method; Female; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Naproxen; Norethindrone; Postpartum Period; Pregnancy; Tranexamic Acid; Uterine Hemorrhage | 1991 |
Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-I.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Cholesterol; Cholesterol, HDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Sex Hormone-Binding Globulin | 1991 |
Estrogen-progestogen once-a-month injectable contraceptives and serum prolactin.
Topics: Adult; Algestone Acetophenide; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Estradiol; Female; Humans; Injections; Intrauterine Devices, Copper; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Prolactin; Random Allocation | 1989 |
Comparative evaluation of two once-a-month contraceptive injections.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pakistan; Periodicity; Time Factors | 1989 |
[Prospective perimenopausal estrogen-progestin substitution therapies for the prevention of osteoporosis].
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Estradiol; Estriol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Prospective Studies | 1989 |
[Emergency ambulatory treatment of dysfunctional metrorrhagia in adolescents].
Topics: Adolescent; Ambulatory Care; Drug Combinations; Drug Evaluation; Emergencies; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Metrorrhagia; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes | 1989 |
Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Proteins; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone | 1989 |
A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection. II. The comparison of bleeding patterns. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility
Topics: Amenorrhea; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Multicenter Studies as Topic; Norethindrone; Randomized Controlled Trials as Topic | 1989 |
A study of adrenal corticol function and its reserve activity in long-acting injectable contraceptive users.
Topics: Adrenal Cortex; Adult; Blood Glucose; Contraceptive Agents, Female; Drug Evaluation; Female; Humans; Hydrocortisone; Hypoglycemia; Injections, Intravenous; Insulin; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone | 1988 |
Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception.
Topics: Administration, Intravaginal; Clinical Trials as Topic; Contraception; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medical Records; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone; Norethindrone Acetate; Norgestrel; Ovulation Detection; Research Design | 1988 |
Acceptability of injectable contraceptives in Assiut, Egypt.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Evaluation; Egypt; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Pregnancy; Pregnancy, Unwanted | 1988 |
Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report.
Topics: Adult; Amenorrhea; Clinical Trials as Topic; Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Administration Schedule; Female; Fertility; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pregnancy | 1983 |
Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Topics: Adult; Contraceptive Agents, Female; Erythromycin; Estradiol; Estrone; Ethinyl Estradiol; Feces; Female; Humans; Intestines; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Norethindrone; Oxytetracycline; Trimethoprim | 1984 |
A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
Topics: Adult; Amenorrhea; Bangladesh; Clinical Trials as Topic; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Pregnancy; Random Allocation | 1980 |
WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
Topics: Amenorrhea; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; World Health Organization | 1982 |
Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women.
Topics: Analysis of Variance; Bone Density; Climacteric; Drug Administration Schedule; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Patient Compliance; Sex Hormone-Binding Globulin; Time Factors | 1995 |
A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effects.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; China; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation Disturbances; Norethindrone; Patient Dropouts | 1995 |
A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patterns.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation Disturbances; Norethindrone | 1995 |
A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
Topics: Adult; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Estrone; Female; Glucuronates; Humans; Injections, Intramuscular; Kinetics; Medroxyprogesterone Acetate; Mexico; Norethindrone; Ovulation; Pregnanediol | 1995 |
Bleeding pattern and climacteric symptoms during different sequential combined HRT regimens in current use.
Topics: Breast; Climacteric; Desogestrel; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Flushing; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menstrual Cycle; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners | 1994 |
Progestogen-only contraceptives during lactation: I. Infant growth. World Health Organization Task force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development and Research Training in Human Reproduction.
Topics: Adolescent; Adult; Anthropometry; Body Weight; Child Development; Chile; Contraceptive Agents, Female; Drug Implants; Egypt; Female; Humans; Hungary; Infant; Kenya; Lactation; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Prospective Studies; Thailand | 1994 |
Progestogen-only contraceptives during lactation: II. Infant development. World Health Organization, Task Force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development, and Research Training in Human Reproduction.
Topics: Adolescent; Adult; Child Development; Chile; Contraceptive Agents, Female; Drug Implants; Egypt; Female; Humans; Hungary; Infant; Kenya; Lactation; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Prospective Studies; Thailand | 1994 |
Acceptability of the once-a-month injectable contraceptives Cyclofem and Mesigyna in Egypt.
Topics: Attitude; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Egypt; Estradiol; Female; Humans; Marriage; Medroxyprogesterone Acetate; Norethindrone; Patient Satisfaction; Retrospective Studies; Surveys and Questionnaires | 1994 |
Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Biopsy; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrium; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Prospective Studies; Uterine Hemorrhage | 1993 |
Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.
Topics: Administration, Cutaneous; Administration, Oral; Cardiovascular Diseases; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipoprotein(a); Lipoproteins, HDL; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone Congeners; Risk Factors | 1996 |
Add-back therapy in the treatment of endometriosis: the European experience.
Topics: Administration, Cutaneous; Bone Density; Double-Blind Method; Drug Combinations; Endometriosis; Estradiol; Estrogen Replacement Therapy; Female; Goserelin; Humans; Injections; Luteinizing Hormone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Treatment Outcome | 1996 |
Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Apolipoprotein A-I; Apolipoprotein A-II; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Estradiol; Estrogen Replacement Therapy; Female; Glycoproteins; Heparin; Humans; Lipolysis; Lipoprotein(a); Lipoproteins, HDL; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone Congeners; Triglycerides | 1997 |
The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Cross-Over Studies; Drug Implants; Drug Synergism; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins, LDL; Medroxyprogesterone Acetate; Norethindrone; Oxidation-Reduction; Postmenopause; Progesterone Congeners | 1997 |
Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on lipid and lipoprotein metabolism. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank,
Topics: Adult; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estradiol; Female; Follow-Up Studies; Humans; Injections; Lipids; Lipoproteins; Longitudinal Studies; Medroxyprogesterone Acetate; Norethindrone; Triglycerides | 1997 |
Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on glucose metabolism and liver function. United Nations Development Programme/United Population Fund/World Health Organization/World Bank, Sp
Topics: Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; gamma-Glutamyltransferase; Glucose Tolerance Test; Humans; Injections; Liver; Longitudinal Studies; Medroxyprogesterone Acetate; Norethindrone | 1998 |
Once-a-month injectable contraceptives, Cyclofem and Mesigyna, in Egypt. Efficacy, causes of discontinuation, and side effects.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Egypt; Estradiol; Female; Humans; Injections, Intravenous; Medroxyprogesterone Acetate; Norethindrone; Patient Compliance; Weight Gain | 1999 |
Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic). Lu
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstrual Cycle; Metrorrhagia; Norethindrone; Patient Compliance; Pregnancy; Weight Gain | 1999 |
Patient acceptability and satisfaction with Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension).
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Patient Satisfaction; Surveys and Questionnaires | 1999 |
Comparative effects of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic) on lipid profiles. Investigator
Topics: Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Lipids; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Triglycerides | 2000 |
Progestins abrogate estrogen-induced changes in the insulin-like growth factor axis.
Topics: Cross-Over Studies; Desogestrel; Drug Interactions; Estrogens; Female; Humans; Insulin; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Progestins; Somatomedins | 2000 |
Negative mood changes during hormone replacement therapy: a comparison between two progestogens.
Topics: Affect; Cross-Over Studies; Double-Blind Method; Estrogen Replacement Therapy; Female; Humans; Medical Records; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Premenstrual Syndrome; Progesterone Congeners | 2000 |
Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other
Topics: Adolescent; Adult; Amenorrhea; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Mestranol; Middle Aged; Norethindrone; Patient Compliance; Uterine Hemorrhage | 2000 |
Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate.
Topics: Aging; Blood Pressure; Double-Blind Method; Drug Combinations; Endometrium; Estradiol; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies | 2001 |
Sensitivity to a neurosteroid is increased during addition of progestagen to postmenopausal hormone replacement therapy.
Topics: Affect; Climacteric; Cross-Over Studies; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Pregnanolone; Progestins; Saccades | 2001 |
A prospective, controlled study of the effects of hormonal contraception on bone mineral density.
Topics: Adolescent; Adult; Bone Density; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Desogestrel; Female; Humans; Lumbar Vertebrae; Medroxyprogesterone Acetate; Multivariate Analysis; Norethindrone; Prospective Studies | 2001 |
Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study.
Topics: Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometrium; Estradiol; Female; France; Germany; Hormone Replacement Therapy; Hot Flashes; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Compliance; Surveys and Questionnaires; Treatment Outcome; Triglycerides; Uterine Hemorrhage | 2001 |
Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
Topics: Administration, Cutaneous; Administration, Oral; Cardiovascular Diseases; Carotid Artery, Internal; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Prospective Studies; Pulsatile Flow | 2001 |
Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor.
Topics: Cholesterol, LDL; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Humans; Levonorgestrel; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Progestins; Risk Factors; Thrombosis; Time Factors; Uterus | 2002 |
Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Topics: Adult; Amenorrhea; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Time Factors; Uterine Hemorrhage | 2003 |
Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.
Topics: Adolescent; Adult; Antithrombins; Blood Coagulation; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Factor VII; Factor X; Female; Fibrinogen; Fibrinolysis; Hemoglobins; Humans; Injections; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Partial Thromboplastin Time; Plasminogen; Plasminogen Inactivators; Platelet Count; Protein C; Prothrombin | 2003 |
Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Adult; C-Reactive Protein; Cross-Sectional Studies; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinogen; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause | 2003 |
Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections.
Topics: Adolescent; Adult; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Lipids; Medroxyprogesterone Acetate; Menstruation Disturbances; Middle Aged; Norethindrone | 2004 |
Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
Topics: Analysis of Variance; Carrier Proteins; Cyproterone Acetate; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin-Like Growth Factor I; Lipids; Liver; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Postmenopause; Progestins; Sex Hormone-Binding Globulin | 2003 |
Effects of hormonal contraception on bone mineral density after 24 months of use.
Topics: Adolescent; Adult; Bone Density; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Time Factors | 2004 |
Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Treatment Outcome; Triglycerides | 2004 |
Endometrial safety and tolerability of triphasic sequential hormone replacement estradiol valerate/medroxyprogesterone acetate therapy regimen.
Topics: Adult; Aged; Biopsy; Climacteric; Contraceptive Agents, Female; Double-Blind Method; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Ultrasonography; Uterine Hemorrhage | 2004 |
A low-dose start in hormone replacement therapy provides a beneficial bleeding profile and few side-effects: randomized comparison with a conventional-dose regimen.
Topics: Aged; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Uterine Hemorrhage | 2004 |
Well-being at onset of hormone replacement therapy: comparison between two continuous combined regimens.
Topics: Breast; Contraceptive Agents, Female; Depression; Double-Blind Method; Edema; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Irritable Mood; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Pain; Postmenopause; Predictive Value of Tests; Prospective Studies; Quality of Life; Sleep Initiation and Maintenance Disorders; Sweating | 2004 |
A comparison of the central effects of different progestins used in hormone replacement therapy.
Topics: Administration, Cutaneous; Anxiety; Body Temperature; Depression; Double-Blind Method; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Hot Flashes; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnadienes; Placebos; Postmenopause; Progestins; Time Factors | 2004 |
Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Cholesterol; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Greece; Humans; Lipids; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Triglycerides | 2004 |
Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
Topics: Apoptosis; Biopsy; Cell Proliferation; Endometrium; Estradiol; Estrogen Receptor alpha; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Ki-67 Antigen; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Receptors, Progesterone; Regression Analysis; Sweden; Uterine Hemorrhage | 2004 |
Long-term effects of two different continuous combined regimens of hormone replacement therapy on well-being.
Topics: Double-Blind Method; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Quality of Life; Sweden | 2004 |
Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinogen; Hemostasis; Humans; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Plasminogen Activator Inhibitor 1; Prospective Studies; Tissue Plasminogen Activator; Treatment Outcome | 2006 |
Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
Topics: Blood Glucose; Cardiovascular Diseases; Desogestrel; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Postmenopause; Progestins; Risk Factors | 2005 |
The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis.
Topics: Administration, Cutaneous; Administration, Oral; Blood Coagulation; C-Reactive Protein; Drug Combinations; Estradiol; Estriol; Female; Hormone Replacement Therapy; Humans; Interleukin-6; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; P-Selectin; Risk Factors; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Venous Thrombosis | 2005 |
The effect of low dose hormone therapy on mammographic breast density.
Topics: Adult; Aged; Breast; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause | 2006 |
Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
Topics: Adult; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Time Factors; Uterine Hemorrhage | 2006 |
The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Drug Therapy, Combination; Female; HIV Seropositivity; HIV-1; Humans; Injections, Intramuscular; Male; Medroxyprogesterone Acetate; Mestranol; Middle Aged; Norethindrone; Reverse Transcriptase Inhibitors; RNA, Viral; Sex Factors; Viral Load; Zidovudine | 2006 |
Comparison of two forms of continuous combined hormone replacement therapy with respect to metabolic effects.
Topics: Adult; Body Weight; Cholesterol; Contraceptive Agents, Female; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipoproteins; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Triglycerides | 2007 |
Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
Topics: Adult; Age Distribution; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Female; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Prospective Studies; Risk Factors; Sexual Behavior; Sexually Transmitted Diseases; South Africa; Time Factors; Uterine Cervical Neoplasms | 2007 |
Effects of postmenopausal hormone replacement therapy on body fat composition.
Topics: Abdominal Fat; Administration, Cutaneous; Administration, Oral; Adult; Body Fat Distribution; Body Weight; Cardiovascular Diseases; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Risk Factors; Waist-Hip Ratio | 2007 |
The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
Topics: Analysis of Variance; Blood Coagulation; Blood Coagulation Factors; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinolysis; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Thromboembolism; Venous Thrombosis | 2007 |
The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women.
Topics: Blood Glucose; Carbohydrate Metabolism; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin Resistance; Lipid Metabolism; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Obesity; Progesterone Congeners; Prospective Studies | 2008 |
Hormone therapy affects plasma measures of factor VII-activating protease in younger postmenopausal women.
Topics: Adult; Age Factors; Coronary Disease; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Risk Factors; Serine Endopeptidases | 2010 |
Comparison of the efficacy of three progestins in the treatment of simple endometrial hyperplasia without atypia.
Topics: Adult; Endometrial Hyperplasia; Female; Humans; Lynestrenol; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Progestins; Prospective Studies; Treatment Outcome | 2011 |
Hormonal contraception and the risk of HIV acquisition among women in South Africa.
Topics: Adolescent; Adult; Anti-Infective Agents; Contraceptives, Oral, Hormonal; Female; HIV Seropositivity; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Odds Ratio; Pregnancy; Proportional Hazards Models; Sexual Behavior; South Africa; Vaginal Creams, Foams, and Jellies; Young Adult | 2012 |
Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
Topics: Adult; Cohort Studies; Contraception Behavior; Contraceptive Agents, Female; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Incidence; Medroxyprogesterone Acetate; Norethindrone; Proportional Hazards Models; Risk Factors; South Africa; Tenofovir; Young Adult | 2015 |
Depo-Provera Versus Norethisterone Acetate in Management of Endometrial Hyperplasia Without Atypia.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Disease Management; Endometrial Hyperplasia; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies | 2016 |
Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial.
Topics: Abdominal Pain; Abortion, Legal; Adolescent; Adult; Back Pain; Contraception Behavior; Contraceptive Agents, Female; Drug Implants; Early Termination of Clinical Trials; Female; Follow-Up Studies; Humans; Intrauterine Devices, Copper; Lost to Follow-Up; Medroxyprogesterone Acetate; Norethindrone; Postoperative Period; Pregnancy; Pregnancy Rate; Progestins; South Africa; Young Adult | 2016 |
Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception.
Topics: Adolescent; Adult; Anti-Retroviral Agents; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Interactions; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Pregnancy; Pyrimidines; Young Adult | 2017 |
Effect of injectable progestin-only contraceptives, depot medroxyprogesterone acetate and norethisterone enanthate, on cytokine production during T-cell activation.
Topics: CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Contraceptive Agents, Female; Female; Humans; Injections; Interferon-gamma; Intrauterine Devices, Copper; Lymphocyte Activation; Medroxyprogesterone Acetate; Norethindrone; Progestins; Young Adult | 2021 |
Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis.
Topics: Adolescent; Adult; Africa South of the Sahara; Contraceptive Agents, Female; Contraceptive Agents, Hormonal; Cross-Over Studies; Cytokines; Female; Genitalia, Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Microbiota; Norethindrone; Prospective Studies; RNA, Ribosomal, 16S; Sexually Transmitted Diseases; Vaginosis, Bacterial; Young Adult | 2021 |
208 other study(ies) available for norethindrone and medroxyprogesterone acetate
| Article | Year |
|---|---|
Quantitative relationships between steroid structure and binding to putative progesterone receptors.
Topics: Androstenes; Animals; Guinea Pigs; Humans; Hydroxyprogesterones; Protein Binding; Rabbits; Receptors, Progesterone; Sheep; Steroids; Structure-Activity Relationship | 1977 |
5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists: the effect of D-ring substituents.
Topics: Animals; Cell Line; Female; Humans; In Vitro Techniques; Magnetic Resonance Spectroscopy; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Structure-Activity Relationship; Uterus | 1998 |
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
Topics: Benzhydryl Compounds; Binding Sites; Diethylstilbestrol; Endocrine System; Hydrocarbons, Chlorinated; Ligands; Models, Molecular; Molecular Conformation; Phenols; Phytoestrogens; Quantitative Structure-Activity Relationship; Receptors, Androgen; Testosterone; Thermodynamics; Xenobiotics | 2005 |
An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.
Topics: Binding Sites; Binding, Competitive; Computer Simulation; Databases as Topic; Humans; Ligands; Linear Models; Models, Molecular; Predictive Value of Tests; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Sex Hormone-Binding Globulin; Steroids | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
The effects of two fixed hormonal replacement therapy protocols on blood lipid profile.
Topics: Clinical Protocols; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Prospective Studies | 1992 |
Continuous combined conjugated equine estrogen-progestogen therapy: effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis.
Topics: Amenorrhea; Atrophy; Drug Therapy, Combination; Endometrium; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Time Factors; Uterine Hemorrhage | 1992 |
A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
Topics: Adult; Apolipoproteins; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Female; Humans; Injections; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Prospective Studies; Time Factors; Triglycerides | 1992 |
Effects of prolonged administration of the 19-nor-testosterone derivatives norethindrone and norgestrel to female NZB/W mice: comparison with medroxyprogesterone and ethinyl estradiol.
Topics: Animals; Antibodies, Antinuclear; Contraceptives, Oral, Hormonal; Disease Models, Animal; Ethinyl Estradiol; Female; Longevity; Lupus Erythematosus, Systemic; Lupus Nephritis; Medroxyprogesterone Acetate; Mice; Mice, Inbred NZB; Norethindrone; Norgestrel; Time Factors; Urinary Tract | 1991 |
Effects of sex steroids on skin 5 alpha-reductase activity in vitro.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adult; Dose-Response Relationship, Drug; Estradiol; Ethinyl Estradiol; Female; Humans; In Vitro Techniques; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norgestrel; Progesterone; Skin; Steroids | 1991 |
Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells.
Topics: Breast Neoplasms; Cell Division; Estradiol; Gene Expression Regulation; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Promegestone; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Tamoxifen; Transforming Growth Factor beta; Tumor Cells, Cultured | 1991 |
[Contraception with cyclic administration of buserelin and gestagens: increase in testosterone and free testosterone serum concentration].
Topics: Administration, Intranasal; Adult; Buserelin; Contraceptives, Oral, Combined; Female; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Protein Binding; Testosterone | 1991 |
Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study.
Topics: Adult; Aged; Breast; Delayed-Action Preparations; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Longitudinal Studies; Mammography; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Retrospective Studies; X-Ray Intensifying Screens | 1990 |
Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy.
Topics: Drug Therapy, Combination; Endometriosis; Estrogen Replacement Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Uterine Neoplasms | 1990 |
[Doctors and injectable contraception. Analysis of the logistics of prescribing in accordance with the views expressed by doctors].
Topics: Attitude of Health Personnel; Attitude to Health; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Cultural Characteristics; Family Planning Services; Female; France; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Patient Care Team; Physician-Patient Relations; Practice Patterns, Physicians'; Socioeconomic Factors | 1990 |
Progestins modulate the action of estrogen on gonadotropin-releasing hormone, luteinizing hormone and prolactin in the rat.
Topics: Animals; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Female; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Pituitary Gland; Pituitary Hormone-Releasing Hormones; Progestins; Prolactin; Radioimmunoassay; Rats; Rats, Inbred Strains | 1990 |
Comparison of norethindrone and medroxyprogesterone acetate with natural progesterone and estradiol in stimulating prolactin production from cultured endometrial stromal cells.
Topics: Analysis of Variance; Cell Count; Cell Division; Cells, Cultured; Drug Synergism; Endometrium; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Progesterone; Prolactin; Proteins; Regression Analysis; Stimulation, Chemical | 1990 |
Treatment of ovulatory and anovulatory dysfunctional uterine bleeding with oral progestogens.
Topics: Adolescent; Adult; Anovulation; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menorrhagia; Middle Aged; Norethindrone; Ovulation; Time Factors | 1990 |
Oral contraceptives and breast cancer: laboratory evidence.
Topics: Animals; Chlormadinone Acetate; Contraceptives, Oral; Contraceptives, Oral, Combined; Dogs; Female; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mestranol; Mice; Norethindrone; Norethynodrel; Rats | 1985 |
Induction of estradiol dehydrogenase activity in human uterine endometrium by synthetic steroids.
Topics: 17-Hydroxysteroid Dehydrogenases; Chlormadinone Acetate; Danazol; Endometrium; Enzyme Induction; Estradiol Dehydrogenases; Female; Gestrinone; Humans; In Vitro Techniques; Lynestrenol; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Progesterone; Steroids | 1988 |
The inductive effects of progestogens on aromatase activity in stromal cells of human uterine endometrium.
Topics: Aromatase; Cells, Cultured; Endometrium; Enzyme Induction; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstrual Cycle; Norethindrone | 1989 |
Mechanism of antitumoral activity of medroxyprogesterone acetate for endometrial cancer.
Topics: Antineoplastic Agents; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mifepristone; Norethindrone; Receptors, Progesterone; Tumor Cells, Cultured; Tumor Stem Cell Assay; Uterine Neoplasms | 1989 |
Use of progestins.
Topics: Cholesterol, HDL; Cholesterol, LDL; Drug Combinations; Estradiol; Estradiol Congeners; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Norgestrel; Progestins; Time Factors | 1989 |
The effects of long-acting injectable contraceptives on carbohydrate metabolism.
Topics: Adult; Blood Glucose; Carbohydrate Metabolism; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Glucose Tolerance Test; Humans; Hydrocortisone; Insulin; Longitudinal Studies; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Pyruvates; Time Factors | 1985 |
Modulation of aromatase activity in human endometrial stromal cells by steroids, tamoxifen and RU 486.
Topics: Adult; Aromatase; Dexamethasone; Dose-Response Relationship, Drug; Endometrium; Estrenes; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Mifepristone; Norethindrone; Progesterone; Progestins; Promegestone; Steroids; Tamoxifen; Testosterone; Time Factors | 1986 |
Effect of Depo-Provera and Noristerat on some biochemical constituents of rat uterus.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Contraceptive Agents, Female; Female; Lipid Metabolism; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Rats; Rats, Inbred Strains; Uterus | 1986 |
Pharmacokinetics of progestational compounds.
Topics: Absorption; Aged; Blood Proteins; Drug Interactions; Female; Humans; Kinetics; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norgestrel; Osmolar Concentration; Progestins | 1986 |
Assessment of the potency of orally administered progestins in women.
Topics: Administration, Oral; Adult; Age Factors; DNA; Dose-Response Relationship, Drug; Drug Evaluation; Dydrogesterone; Endometrium; Estradiol Dehydrogenases; Female; Glycogen; Humans; Isocitrate Dehydrogenase; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Progesterone; Progesterone Congeners; Reference Values | 1986 |
[Therapy with gestagens in hyperplastic changes of the endometrium].
Topics: Adenocarcinoma; Adenoma; Endometrial Hyperplasia; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Norethindrone Acetate; Uterine Neoplasms | 1986 |
Menstrual changes associated with progestogen-only contraception.
Topics: Administration, Oral; Amenorrhea; Contraceptive Agents, Female; Counseling; Estrogens; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Norgestrel; Time Factors | 1986 |
New regimen of injectable contraceptives.
Topics: Adult; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone | 1987 |
Pituitary response to LHRH in long-term users of injectable contraceptives.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Injections; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone | 1987 |
Effects of prenatal administration of mestranol and two progestins on testosterone synthesis and reproductive tract development in male rats.
Topics: Animals; Ethinyl Estradiol; Female; Male; Maternal-Fetal Exchange; Medroxyprogesterone; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Organ Size; Placenta; Pregnancy; Prostate; Rats; Rats, Inbred Strains; Seminal Vesicles; Testis; Testosterone | 1987 |
[Hormone dependency and progestogen therapy in the treatment of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cell Division; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Norethindrone; Tamoxifen; Tumor Stem Cell Assay; Uterine Neoplasms | 1987 |
[Parenteral contraceptive drugs: depot progestins].
Topics: Administration, Intravaginal; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstrual Cycle; Norethindrone; Pregnancy | 1987 |
[Progestogen therapy in the treatment of endometrial cancer--clinical results and mechanism of steroid action].
Topics: Estrenes; Female; Humans; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Mifepristone; Neoplasms, Hormone-Dependent; Norethindrone; Norgestrel; Progesterone Congeners; Receptors, Progesterone; Tumor Stem Cell Assay; Uterine Neoplasms | 1988 |
Histological changes in the ovary and uterus of rat after injectable contraceptive therapy.
Topics: Animals; Contraception; Contraceptive Agents; Female; Injections, Subcutaneous; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Ovary; Rats; Rats, Inbred Strains; Uterus | 1988 |
Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.
Topics: Administration, Cutaneous; Adult; Contraceptive Agents, Male; Dihydrotestosterone; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Sperm Count; Spermatogenesis; Testosterone | 1988 |
Progesterone and progestins modulate beta-endorphin concentrations in the hypothalamus and in the pituitary of castrated female rats.
Topics: Animals; beta-Endorphin; Desogestrel; Estradiol; Female; Hypothalamus, Middle; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Ovariectomy; Pituitary Gland; Pituitary Gland, Anterior; Progesterone; Progestins; Radioimmunoassay; Rats; Rats, Inbred Strains | 1987 |
Injectable contraception.
Topics: Contraceptive Agents, Female; Contraceptives, Oral; Female; Humans; Injections, Subcutaneous; Intrauterine Devices; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone | 1988 |
Dysfunctional uterine bleeding.
Topics: Adult; Contraceptives, Oral; Cyclooxygenase Inhibitors; Dilatation and Curettage; Dinoprost; Dinoprostone; Emergencies; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Mefenamic Acid; Menorrhagia; Norethindrone; Progesterone; Prostaglandins E; Prostaglandins F | 1986 |
[Effectiveness of injectable contraceptives in Mexican women].
Topics: Adolescent; Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Evaluation; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mexico; Norethindrone; Patient Acceptance of Health Care; Patient Dropouts; Pregnancy | 1985 |
Return to ovulation following the use of long-acting injectable contraceptives: a comparative study.
Topics: Adult; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstrual Cycle; Norethindrone; Ovulation; Progesterone; Time Factors | 1985 |
Vasomotor symptoms and estrogen-progestogen therapy.
Topics: Adult; Climacteric; Contraceptives, Oral, Combined; Estradiol; Estriol; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norgestrel; Progesterone; Progestins; Vasomotor System | 1985 |
Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations.
Topics: Adult; Biopsy; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Endometrium; Estradiol; Female; Humans; Injections; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone; Ovulation; Progesterone | 1985 |
Biochemical effect of non-antiovulatory doses of different progestins on cycling rat uterus.
Topics: Animals; DNA; Estrus; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Proteins; Rats; RNA; Uterus | 1980 |
Changes in the binding of oestradiol to uterine oestrogen receptors induced by some progesterone and 19-nor-testosterone derivatives.
Topics: Animals; Chlormadinone Acetate; Cytoplasm; Estradiol; Female; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Rats; Receptors, Estradiol; Receptors, Estrogen; Uterus | 1983 |
Facts about injectable contraceptives: memorandum from a WHO meeting.
Topics: Animals; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Pregnancy; World Health Organization | 1982 |
Transfer of contraceptive steroids in milk of women using long-acting gestagens.
Topics: Adult; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norethindrone | 1982 |
Long-acting progestins--promise and prospects.
Topics: Animals; Bibliographies as Topic; Breast Neoplasms; Contraceptives, Oral, Combined; Delayed-Action Preparations; Dogs; Female; Haplorhini; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Progesterone Congeners; Rats; Reproduction; Uterine Neoplasms | 1983 |
Neonatal exposure to a progestin via milk alters subsequent LH cyclicity in the female rat.
Topics: Animals; Animals, Newborn; Animals, Suckling; Female; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk; Norethindrone; Pregnancy; Proestrus; Progesterone; Progestins; Rats; Rats, Inbred Strains | 1984 |
A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
Topics: Amenorrhea; Contraceptive Agents, Female; Curettage; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menorrhagia; Menstruation Disturbances; Norethindrone; Oligomenorrhea | 1983 |
Injectable contraception.
Topics: Adult; Cervix Mucus; Contraceptive Agents, Female; Endometrium; Female; Humans; Injections, Intramuscular; Kinetics; Lactation; Lipid Metabolism; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Uterine Hemorrhage | 1984 |
[Injectable contraception using depot progestagens].
Topics: Animals; Contraceptive Agents, Female; Delayed-Action Preparations; Dogs; Embryonic and Fetal Development; Female; Fertility; Humans; Macaca mulatta; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pregnancy | 1983 |
Mechanisms of uterine bleeding in postmenopausal patients receiving estrogen alone or with a progestin.
Topics: Adult; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Histocytochemistry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Microscopy, Electron; Middle Aged; Norethindrone; Norethindrone Acetate; Substance Withdrawal Syndrome; Uterine Hemorrhage | 1983 |
Chromosomally competent ovarian failure at adolescence.
Topics: Adolescent; Contraceptives, Oral, Combined; Diagnosis, Differential; Drug Combinations; Estrogens, Conjugated (USP); Female; Gonadal Dysgenesis; Humans; Karyotyping; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause, Premature; Menstruation Disturbances; Mestranol; Norethindrone; Norethynodrel; Ovarian Function Tests; Ovary; Turner Syndrome | 1983 |
Serum copper and zinc in hormonal contraceptive users.
Topics: 20-alpha-Dihydroprogesterone; Contraceptive Devices, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Copper; Estradiol; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Zinc | 1980 |
Use of the progestogen challenge test to reduce the risk of endometrial cancer.
Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Precancerous Conditions; Progesterone; Prospective Studies; Risk; Uterine Neoplasms | 1980 |
Effect of non-antiovulatory doses of norethindrone & depoprovera on implantation in rat.
Topics: Animals; Dose-Response Relationship, Drug; Embryo Implantation; Female; Lysosomes; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Ovulation; Pregnancy; Rats; Uterus | 1980 |
On the mechanism of action of progestins.
Topics: Castration; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Pituitary Gland; Progesterone; Progesterone Congeners; Receptors, Androgen | 1981 |
High density lipoprotein cholesterol and apolipoprotein A-I levels in 32-33-year-old women on steroid contraceptives-differences between two frequently used low-estrogen pills.
Topics: Adult; Alcohol Drinking; Apolipoprotein A-I; Apolipoproteins; Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Delayed-Action Preparations; Ethinyl Estradiol; Female; Humans; Lipoproteins, HDL; Lynestrenol; Medroxyprogesterone; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Smoking | 1981 |
Lipid metabolic studies in oophorectomized women: effects of synthetic progestogens on individual serum phospholipids and serum lecithin fatty acid composition.
Topics: Adult; Castration; Fatty Acids; Female; Humans; Levonorgestrel; Liver Function Tests; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Phosphatidylcholines; Phospholipids; Progesterone Congeners | 1982 |
Mechanism of action of contraceptive synthetic progestins.
Topics: Androgen-Insensitivity Syndrome; Animals; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Norethindrone; Ovary; Rabbits; Rats; Receptors, Steroid; Sheep | 1981 |
Postmenopausal hormone replacement therapy and plasma lipoproteins.
Topics: Aged; Cardiovascular Diseases; Cholesterol, HDL; Double-Blind Method; Drug Combinations; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Multicenter Studies as Topic; Norethindrone; Norethindrone Acetate; Norgestrel; Postmenopause; Progesterone Congeners; Progestins; Randomized Controlled Trials as Topic; Risk Factors | 1995 |
"Rollerball" ablation of the endometrium.
Topics: Electrocoagulation; Endometrium; Female; Humans; Hysterectomy; Leuprolide; Life Tables; Medroxyprogesterone Acetate; Menorrhagia; Norethindrone; Norethindrone Acetate; Postoperative Complications; Reoperation; Uterine Hemorrhage | 1995 |
Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Topics: Administration, Oral; Adolescent; Adult; Apolipoprotein A-I; Bilirubin; Body Weight; Cholesterol; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; Humans; Injections, Intramuscular; Levonorgestrel; Lipoproteins; Medroxyprogesterone Acetate; Menstrual Cycle; Norethindrone; Progestins; Sex Hormone-Binding Globulin; Time Factors; Triglycerides; United States | 1995 |
Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills)--an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research.
Topics: Administration, Oral; Adolescent; Adult; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Estradiol; Female; Humans; India; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation Disturbances; Multicenter Studies as Topic; Norethindrone; Randomized Controlled Trials as Topic | 1995 |
Regression of endometrial thickness in combination with reduced withdrawal bleeding as a progestational effect of tibolone in postmenopausal women on oestrogen replacement therapy.
Topics: Adult; Aged; Endometrium; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Progestins; Uterine Hemorrhage | 1995 |
Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy.
Topics: Aged; Aged, 80 and over; Biopsy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Norethindrone; Norethindrone Acetate; Progestins; Retrospective Studies | 1994 |
Once-a-month injectable contraceptives.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone | 1993 |
Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
Topics: Adult; Contraceptives, Oral; Drug Administration Schedule; Estradiol; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Medroxyprogesterone Acetate; Menstruation; Mifepristone; Norethindrone; Ovarian Follicle; Progesterone; Prospective Studies | 1993 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Desogestrel; Estradiol; Estrogen Antagonists; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Models, Statistical; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured | 1995 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Estrenes; Estrogen Antagonists; Female; Furans; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Tumor Cells, Cultured | 1995 |
Injectable contraception and lactation.
Topics: Contraceptive Agents, Female; Female; Humans; Injections; Medroxyprogesterone Acetate; Milk, Human; Norethindrone | 1995 |
Long-term compliance of continuous combined estrogen and progestogen replacement in postmenopausal women.
Topics: Adult; Aged; Climacteric; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Gonadal Steroid Hormones; Humans; Levonorgestrel; Long-Term Care; Medroxyprogesterone Acetate; Menstrual Cycle; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Compliance; Progestins | 1996 |
Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Topics: Breast Neoplasms; Endometrial Neoplasms; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphokines; Medroxyprogesterone Acetate; Megestrol Acetate; Mifepristone; Neoplasm Proteins; Neovascularization, Pathologic; Norethindrone; Norethynodrel; Norgestrel; Progesterone; Progestins; Receptors, Progesterone; Stimulation, Chemical; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women.
Topics: Copper Sulfate; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Lipoproteins, LDL; Malondialdehyde; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norgestrel; Oxidation-Reduction; Postmenopause; Progesterone; Progesterone Congeners; Testosterone | 1998 |
The effects of progesterone and progestins on endometrial proliferation.
Topics: Atrophy; Biopsy; Cell Division; Contraceptives, Oral; Cyclins; Endometrium; Female; Humans; Medroxyprogesterone Acetate; Mestranol; Middle Aged; Mitosis; Norethindrone; Norethindrone Acetate; Norethynodrel; Postmenopause; Premenopause; Progesterone Congeners; Proliferating Cell Nuclear Antigen; Stromal Cells | 1998 |
Estradiol inhibits LDL oxidation: do the progestins medroxyprogesterone acetate and norethisterone acetate influence this effect?
Topics: Drug Interactions; Estradiol; Female; Hormone Replacement Therapy; Humans; Lipoproteins, LDL; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Oxidation-Reduction; Progesterone Congeners | 1998 |
Twelve years of injectable contraceptive use in a general practice.
Topics: Adolescent; Adult; Child; Contraceptive Agents, Female; Family Practice; Female; Humans; Injections, Subcutaneous; London; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Practice Patterns, Physicians'; Progesterone Congeners; Retrospective Studies | 1998 |
Progesterone analogues similarly modulate endometrial matrix metalloproteinase-1 and matrix metalloproteinase-3 and their inhibitor in a model for long-term contraceptive effects.
Topics: Adult; Androstenes; Cells, Cultured; Collagenases; Contraceptive Agents, Female; Endometrium; Female; Humans; Levonorgestrel; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Pregnenediones; Progesterone; Progesterone Congeners; Stromal Cells; Tissue Inhibitor of Metalloproteinase-1 | 1999 |
Acceptability of once-a-month injectable contraceptives Cyclofem and Mesigyna: focus group discussion.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Counseling; Drug Combinations; Egypt; Estradiol; Female; Focus Groups; Humans; Islam; Medroxyprogesterone Acetate; Norethindrone; Patient Satisfaction; Social Support | 1999 |
Counting the costs: comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa.
Topics: Adolescent; Adult; Age Factors; Choice Behavior; Contraceptive Agents, Female; Developing Countries; Drug Costs; Drugs, Essential; Female; Fertility; Health Expenditures; Health Services Needs and Demand; Humans; Injections; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Pharmacies; South Africa; Treatment Outcome | 2001 |
Mammographic density changes during different postmenopausal hormone replacement therapies.
Topics: Cyproterone Acetate; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Progesterone Congeners; Retrospective Studies; Time Factors | 2001 |
Effect of conjugated estrogens on free IGF-I?
Topics: Desogestrel; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Medroxyprogesterone Acetate; Norethindrone | 2001 |
The effect of medroxyprogesterone acetate and norethisterone on the estradiol stimulated proliferation in MCF-7 cells: comparison of continuous combined versus sequential combined estradiol/progestin treatment.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Estradiol; Estrogen Replacement Therapy; Female; Humans; In Vitro Techniques; Medroxyprogesterone Acetate; Norethindrone; Progesterone Congeners; Progestins; Tumor Cells, Cultured | 2001 |
Temporary discontinuation: a compliance issue in injectable users.
Topics: Adult; Cohort Studies; Contraception Behavior; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Injections; Medroxyprogesterone Acetate; Norethindrone; Patient Acceptance of Health Care; Patient Compliance | 2001 |
Use of progestogen-only contraceptives/medications and lipid parameters in women age 40 to 42 years: results of a population-based cross-sectional Norwegian Survey.
Topics: Administration, Oral; Adult; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cross-Sectional Studies; Delayed-Action Preparations; Female; Health Surveys; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Lipoproteins; Lynestrenol; Medroxyprogesterone Acetate; Norethindrone; Norway; Progestins; Risk Factors; Triglycerides | 2002 |
Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins.
Topics: Arteriosclerosis; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Humans; Intercellular Adhesion Molecule-1; Interleukin-1; Levonorgestrel; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Receptors, Androgen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; Umbilical Veins; Vascular Cell Adhesion Molecule-1 | 2002 |
Once-a-month estrogen/progestogen injectables.
Topics: Amenorrhea; Asia; Asia, Eastern; Biology; Blood; Blood Coagulation; Carbohydrates; China; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Developing Countries; Disease; Endocrine System; Endometrium; Family Planning Services; Fibrinolysis; Genitalia; Genitalia, Female; Glucose; Hemorrhage; Hormones; Injections; International Agencies; Lipids; Medroxyprogesterone Acetate; Megestrol Acetate; Menstruation Disturbances; Metabolism; Norethindrone; Organizations; Ovulation; Patient Acceptance of Health Care; Physiology; Progesterone; Progestins; Reproduction; Research; Signs and Symptoms; United Nations; Urogenital System; Uterus; World Health Organization | 1991 |
Steroids.
Topics: Adrenal Cortex Hormones; Africa; Americas; Asia; Biology; Chlormadinone Acetate; Contraception; Contraceptives, Oral; Developed Countries; Developing Countries; Dimethisterone; Economics; Endocrine System; Estradiol; Ethynodiol Diacetate; Europe; Europe, Eastern; Family Planning Services; Germany, West; Hormones; Italy; Latin America; Medroxyprogesterone Acetate; Megestrol Acetate; Mestranol; Mexico; Netherlands; Norethindrone; Norethynodrel; Norgestrel; North America; Physiology; Progesterone; Progestins; Research; Switzerland; Technology; Testosterone; United Kingdom; United States | 1969 |
A new approach to fertility control: long-acting injectable progesterones.
Topics: Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Family Planning Services; Injections; Medroxyprogesterone Acetate; Norethindrone; Research | 1968 |
The relation of the structure of progestational steroids to nucleolar differentiation in human endometrium.
Topics: Biology; Cells; Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Dimethisterone; Endocrine System; Endometrium; Ethynodiol Diacetate; Family Planning Services; Genitalia; Genitalia, Female; Histology; Hormones; In Vitro Techniques; Medroxyprogesterone Acetate; Norethindrone; Norethynodrel; Norgestrel; Physiology; Progesterone; Progestins; Research; Urogenital System; Uterus | 1972 |
Ovarian morphological changes with injectable contraceptives and their relation to cycle control.
Topics: Amenorrhea; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Corpus Luteum; Disease; Endometrium; Family Planning Services; Genitalia; Genitalia, Female; Histology; Injections; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation Disturbances; Norethindrone; Ovary; Ovulation; Physiology; Research; Urogenital System; Uterus; Vagina; Vaginitis | 1971 |
Injectable contraceptives: safe and effective.
Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Family Planning Services; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; Politics | 1982 |
Systemics.
Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Endocrine System; Family Planning Services; Hormones; Medroxyprogesterone Acetate; Norethindrone; Physiology; Reproductive Control Agents; Research | 1985 |
[Preclinical research and development of norethisterone].
Topics: Animals, Laboratory; Biology; Cervix Mucus; Cervix Uteri; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Economics; Endocrine System; Ethinyl Estradiol; Family Planning Services; Genitalia; Genitalia, Female; Hormones; In Vitro Techniques; Levonorgestrel; Medroxyprogesterone Acetate; Membrane Proteins; Norethindrone; Ovulation; Physiology; Proteins; Reproduction; Reproductive Control Agents; Research; Technology; Urogenital System; Uterus | 1985 |
Vaginal rings for contraception: endocrine parameters.
Topics: Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Endocrine Glands; Endocrine System; Estradiol; Estrogens; Ethinyl Estradiol; Family Planning Services; Hormones; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Patient Acceptance of Health Care; Physiology; Progesterone; Progestins | 1992 |
Progestin-only injectables offer many advantages.
Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Family Planning Services; Health; Injections; Medroxyprogesterone Acetate; Norethindrone; Public Health; Safety | 1995 |
Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Cross-Sectional Studies; Family Characteristics; Female; Focus Groups; Health Knowledge, Attitudes, Practice; Humans; Injections, Intramuscular; Interviews as Topic; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Qualitative Research; Rural Population; Sexual Partners; South Africa; Vaginal Discharge | 2002 |
Injectable steroids as a method of contraception.
Topics: Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Endocrine System; Evaluation Studies as Topic; Family Planning Services; Hormones; Injections; Medroxyprogesterone Acetate; Norethindrone; Patient Acceptance of Health Care; Physiology; Postpartum Period; Reproductive Control Agents | 1970 |
Return of fertility in women discontinuing injectable contraceptives.
Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Demography; Endocrine System; Family Planning Services; Fertility; Hormones; Injections; Medroxyprogesterone Acetate; Norethindrone; Ovulation; Physiology; Population; Population Dynamics; Reproduction; Reproductive Control Agents; Research | 1986 |
Some metabolic and hormonal changes in women using long acting injectable contraceptives.
Topics: Africa; Africa, Northern; Biology; Blood; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Data Collection; Developing Countries; Egypt; Endocrine System; Estradiol; Estrogens; Evaluation Studies as Topic; Family Planning Services; Follicle Stimulating Hormone; Gonadotropins; Gonadotropins, Pituitary; Hormones; Injections; Luteinizing Hormone; Medroxyprogesterone Acetate; Metabolism; Middle East; Norethindrone; Physiology; Research; Steroids | 1989 |
Choice of injectables in family planning programmes.
Topics: Asia; Bangladesh; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Delivery of Health Care; Developing Countries; Family Planning Services; Health Planning; Health Planning Guidelines; Injections; International Agencies; Medroxyprogesterone Acetate; Norethindrone; Organization and Administration; Organizations | 1992 |
Newer synthetic progestins for the treatment of endometriosis.
Topics: Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Digestive System; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Hemorrhage; Injections; Lynestrenol; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation; Mestranol; Metrorrhagia; Nausea; Norethindrone; Norethynodrel; Pseudopregnancy; Reproduction; Signs and Symptoms; Thromboembolism; Vascular Diseases | 1970 |
Mutual modification of glucose-stimulated serum insulin responses in female rhesus monkeys by ethinyl estradiol and nortestosterone derivatives.
Topics: Animals, Laboratory; Biology; Carbohydrates; Clinical Laboratory Techniques; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Diagnosis; Ethinyl Estradiol; Family Planning Services; Glucose; Glucose Tolerance Test; Medroxyprogesterone Acetate; Mestranol; Metabolism; Norethindrone; Physiology; Research | 1975 |
[Gas chromatography of oral progestagens and estrogens].
Topics: Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Dimethisterone; Ethinyl Estradiol; Family Planning Services; Lynestrenol; Medroxyprogesterone Acetate; Megestrol Acetate; Mestranol; Norethindrone; Norgestrel | 1968 |
Chemistry, pharmacology and clinical pharmacology of oral contraceptives.
Topics: Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Ethynodiol Diacetate; Family Planning Services; Lynestrenol; Medroxyprogesterone Acetate; Megestrol Acetate; Norethindrone; Norethynodrel | 1968 |
[What happens in our patients' bodies to the steroid hormones we prescribe? 2. Synthetic progestins].
Topics: Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Ethynodiol Diacetate; Family Planning Services; Lynestrenol; Medroxyprogesterone Acetate; Megestrol Acetate; Norethindrone; Norgestrel | 1981 |
Management of amenorrhea due to contraceptive injectables by temporary IUD insertion.
Topics: Age Factors; Amenorrhea; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Diagnosis; Disease; Family Planning Services; Hemorrhage; Injections; Intrauterine Devices; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Patient Acceptance of Health Care; Retention, Psychology; Therapeutics | 1982 |
[Indications and medical survey of long acting progestatives used for contraception (author's transl)].
Topics: Amenorrhea; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Family Planning Services; Injections; Medroxyprogesterone Acetate; Norethindrone; Psychology; Reproductive Control Agents | 1982 |
Statement on injectable contraception.
Topics: Animals, Laboratory; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Endometrial Neoplasms; Family Planning Services; Injections; International Agencies; Lactation; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; Organizations; Research; Steroids; Uterine Cervical Neoplasms | 1982 |
The future for injectable contraceptives.
Topics: Africa; Africa South of the Sahara; Africa, Eastern; Birth Rate; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Demography; Developing Countries; Family Planning Services; Fertility; Injections; International Agencies; Kenya; Medroxyprogesterone Acetate; Norethindrone; Organizations; Population; Population Dynamics | 1993 |
Injectable contraception: the USA perspective.
Topics: Americas; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Endometrial Neoplasms; Evaluation Studies as Topic; Family Planning Services; Government Agencies; Health Services Accessibility; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; North America; Organizations; United States; United States Food and Drug Administration; United States Public Health Service | 1992 |
Statement on injectable contraception. Revised.
Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Endocrine System; Estradiol; Estrogens; Family Planning Services; Hormones; Injections; Medroxyprogesterone Acetate; Norethindrone; Physiology | 1992 |
Millions of couples to have choice of injectable contraceptive.
Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Family Planning Services; Injections; Medroxyprogesterone Acetate; Norethindrone | 1996 |
Vaginal discharge: a perceived side effect and minor reason for discontinuation in hormonal injectable users in South Africa.
Topics: Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; Patient Compliance; South Africa; Vaginal Discharge | 2001 |
The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
Topics: Analysis of Variance; Breast Neoplasms; Cell Division; Chlormadinone Acetate; Culture Media; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Progesterone; Progestins; Tumor Cells, Cultured | 2003 |
Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys.
Topics: Animals; Aorta; Cardiotonic Agents; Cardiovascular System; Cholesterol; Coronary Angiography; Coronary Vessels; Dobutamine; Drug Combinations; Electroencephalography; Endometrium; Epithelium; Estradiol Congeners; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Lipids; Macaca fascicularis; Mammary Glands, Animal; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone Congeners; Uterus; Vasoconstriction | 2003 |
Comparison of the effect of progesterone, medroxyprogesterone acetate and norethisterone on the proliferation of human breast cancer cells.
Topics: Breast; Cell Division; Cells, Cultured; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Progesterone | 2003 |
Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.
Topics: Adult; Antineoplastic Agents, Hormonal; Biopsy; Cell Division; Cells, Cultured; Endometrium; Female; Glycogen; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnadienes; Progesterone Congeners; Progestins; Receptors, Estradiol; Receptors, Progesterone; Time Factors | 2003 |
[The progestational activity of the methylacetoxyprogesterone-norethisterone combination. (Clinical experimentation)].
Topics: Empirical Research; Gynecology; Medroxyprogesterone Acetate; Norethindrone; Progesterone; Research Design | 1961 |
Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
Topics: Breast Neoplasms; Cell Division; Dose-Response Relationship, Drug; Equilin; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Progesterone; Progestins; Tumor Cells, Cultured | 2003 |
Effect of hormone replacement therapy on serum levels of tumor markers in healthy postmenopausal women.
Topics: alpha-Fetoproteins; Biomarkers, Tumor; CA-125 Antigen; CA-19-9 Antigen; Carcinoembryonic Antigen; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medical Records; Medroxyprogesterone Acetate; Middle Aged; Mucin-1; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone; Prospective Studies; Retrospective Studies; Turkey | 2003 |
Detection of raised FSH levels among older women using depomedroxyprogesterone acetate and norethisterone enanthate.
Topics: Adult; Biomarkers; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Predictive Value of Tests | 2003 |
Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, and 17beta-estradiol on vascular endothelial growth factor isomers 121 and 165 in Ishikawa cells.
Topics: Adenocarcinoma; Endometrial Neoplasms; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Prospective Studies; Protein Isoforms; Receptors, Progesterone; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2004 |
Progestins initiate adverse events of menopausal estrogen therapy.
Topics: Animals; Contraceptive Agents, Female; Endothelium, Vascular; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Fluorescein Angiography; Leukocytes; Medroxyprogesterone Acetate; Norethindrone; Platelet Aggregation; Progesterone; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Thromboembolism; Video Recording | 2003 |
Different cerebrovascular effects of medroxyprogesterone acetate and norethisterone acetate in the New Zealand White rabbit.
Topics: Acetylcholine; Animals; Calcium; Cerebral Arteries; Constriction, Pathologic; Contraceptive Agents, Female; Endometrium; Endothelin-1; Enzyme Inhibitors; Estradiol; Estrogens; Estrogens, Conjugated (USP); Female; Medroxyprogesterone Acetate; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitroprusside; Norethindrone; Norethindrone Acetate; Ovariectomy; Potassium; Rabbits; Random Allocation; Vasodilator Agents | 2004 |
Wayward sisters. Progestin siblings exert opposite effects on monkey hearts.
Topics: Animals; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Haplorhini; Heart; Heart Diseases; Humans; Medroxyprogesterone Acetate; Norethindrone; Progestins | 2004 |
Effect of previous hormone replacement therapy on endometrial polyps during menopause.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Case-Control Studies; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Immunohistochemistry; Ki-67 Antigen; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Polyps; Proto-Oncogene Proteins c-bcl-2; Receptor, ErbB-2; Retrospective Studies | 2004 |
Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits.
Topics: Acetylcholine; Animals; Arteries; Calcium; Coronary Vessels; Disease Models, Animal; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Medroxyprogesterone Acetate; Menopause; NG-Nitroarginine Methyl Ester; Nitroprusside; Norethindrone; Norethindrone Acetate; Ovariectomy; Potassium; Progestins; Rabbits; Vasoconstriction; Vasodilation | 2004 |
Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception.
Topics: Adult; Body Mass Index; Bone Density; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Cross-Sectional Studies; Employment; Exercise; Female; Follicle Stimulating Hormone; Humans; Marital Status; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; South Africa; Time Factors | 2005 |
Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
Topics: Adult; Aged; Androgens; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin; Insulin Resistance; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sex Hormone-Binding Globulin; Testosterone | 2005 |
Progestins and estrogens and Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cell Adhesion; Cells, Cultured; Cognition; Estradiol; Estradiol Congeners; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Progesterone Congeners; Rats | 2005 |
The effects of hormone replacement on the biomechanical properties of the uterosacral and round ligaments in the monkey model.
Topics: Animals; Biomechanical Phenomena; Drug Synergism; Elasticity; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hormones; Ligaments; Macaca fascicularis; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Ovariectomy; Round Ligament of Uterus; Tensile Strength; Uterus | 2005 |
A comparison of two progestins on myocardial ischemia-reperfusion injury in ovariectomized monkeys receiving estrogen therapy.
Topics: Animals; Biomarkers; Blood Flow Velocity; Blood Pressure; Body Weight; Contraceptive Agents, Female; Coronary Circulation; Disease Models, Animal; Drug Interactions; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Haplorhini; Heart Rate; Lipids; Medroxyprogesterone Acetate; Myocardial Reperfusion Injury; Neovascularization, Physiologic; Norethindrone; Norethindrone Acetate; Ovariectomy; Peroxidase; Progestins; Research Design; Stroke Volume; Vascular Resistance | 2005 |
Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Topics: Administration, Cutaneous; Adrenal Glands; Aging; Dehydroepiandrosterone; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hydrocortisone; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Ovariectomy; Postmenopause; Pregnanolone; Progesterone; Progestins | 2005 |
Synthetic progestins used in HRT have different glucocorticoid agonist properties.
Topics: Animals; Cell Line; Genes, Reporter; Glucocorticoids; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Phosphorylation; Progesterone Congeners; Rats; Receptors, Glucocorticoid; Transcriptional Activation; Transfection; Trypsin | 2005 |
Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells.
Topics: Apoptosis; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Epithelial Cells; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Norethindrone | 2005 |
Injectable contraceptives: a worldwide perspective.
Topics: Animals; Contraceptive Agents, Female; Developing Countries; Female; Global Health; Humans; Injections; Medroxyprogesterone Acetate; Models, Animal; Norethindrone | 2002 |
Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Female; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured | 2005 |
Management quandary. Menstrual issues in a teenager with developmental delay.
Topics: Adolescent; Developmental Disabilities; Female; Humans; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Sterilization, Reproductive; Third-Party Consent | 2006 |
Weight changes in clients on hormonal contraceptives in Zaria, Nigeria.
Topics: Adult; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Retrospective Studies; Weight Gain; Weight Loss | 2005 |
Is there a protective role of progestogens on the proliferation of human ovarian cancer cells in the presence of growth factors?
Topics: Analysis of Variance; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Epidermal Growth Factor; Female; Fibroblast Growth Factors; Humans; In Vitro Techniques; Insulin-Like Growth Factor Binding Proteins; Medroxyprogesterone Acetate; Norethindrone; Ovarian Neoplasms; Progestins; Protective Agents | 2006 |
Preferences between injectable contraceptive methods among South African women.
Topics: Adolescent; Adult; Cross-Sectional Studies; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Patient Education as Topic; Patient Satisfaction; South Africa | 2006 |
Bone mineral density in users of two kinds of once-a-month combined injectable contraceptives.
Topics: Absorptiometry, Photon; Adult; Body Mass Index; Bone Density; Contraceptive Agents, Female; Cross-Sectional Studies; Estradiol; Female; Humans; Injections; Medroxyprogesterone Acetate; Norethindrone; Radius; Ulna | 2006 |
Effects of the components of hormone therapy on matrix metalloproteinases in breast-cancer cells: an in vitro study.
Topics: Breast Neoplasms; Cell Line, Tumor; Equilin; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Progesterone | 2007 |
Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression.
Topics: Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspases; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Female; GPI-Linked Proteins; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Ovarian Neoplasms; Progesterone; Progestins; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor, Member 10c; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor Decoy Receptors | 2007 |
Bone mineral density in adolescents using norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives for contraception.
Topics: Absorptiometry, Photon; Adolescent; Adult; Bone Density; Contraceptives, Oral, Combined; Delayed-Action Preparations; Female; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Norethindrone; Surveys and Questionnaires | 2007 |
In vitro effects of tibolone and its metabolites on human vascular coronary cells.
Topics: Biomarkers; Cells, Cultured; Coronary Vessels; E-Selectin; Endothelins; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Epoprostenol; Estradiol; Female; Humans; Intercellular Adhesion Molecule-1; Matrix Metalloproteinase 1; Medroxyprogesterone Acetate; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Norethindrone; Norpregnenes; Plasminogen Activator Inhibitor 1; Vascular Resistance | 2007 |
Bone status after cessation of use of injectable progestin contraceptives.
Topics: Adolescent; Adult; Ambulatory Care Facilities; Black People; Bone Density; Bone Resorption; Calcaneus; Contraceptive Agents, Female; Cross-Sectional Studies; Delayed-Action Preparations; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; South Africa; Ultrasonography | 2007 |
Estrogen replacement therapy among postmenopausal women and its effects on signs and symptoms of temporomandibular disorders.
Topics: Adult; Age Factors; Aged; Bruxism; Educational Status; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Headache; Health Status; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Postmenopause; Range of Motion, Articular; Risk Factors; Temporomandibular Joint Disorders; Time Factors | 2008 |
Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate.
Topics: Adolescent; Bone Density; Contraceptives, Oral, Combined; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Prospective Studies; Young Adult | 2009 |
Characteristics and recent evolution of menopausal hormone therapy use in a cohort of Swedish women.
Topics: Adult; Cohort Studies; Estradiol; Estrogen Replacement Therapy; Female; Humans; Life Style; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Sweden; Women's Health | 2009 |
Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception.
Topics: Bone Diseases, Metabolic; Case-Control Studies; Contraceptives, Oral, Combined; Cross-Sectional Studies; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; Time; Young Adult | 2009 |
Use of injectable progestin contraception and risk of STI among South African women.
Topics: Adolescent; Adult; Condoms; Female; Humans; Medroxyprogesterone Acetate; Multivariate Analysis; Norethindrone; Patient Selection; Pregnancy; Regression Analysis; Risk Factors; Sexually Transmitted Diseases, Bacterial; South Africa; Vaginitis | 2009 |
Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception.
Topics: Adolescent; Body Mass Index; Body Weight; Contraception Behavior; Contraceptives, Oral, Combined; Female; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Norethindrone; Prospective Studies; Weight Gain; Withholding Treatment; Young Adult | 2010 |
Clinical experience with injectable progestogen- only contraceptives at University of Ilorin teaching hospital: a five year review.
Topics: Adult; Age Distribution; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Educational Status; Female; Hospitals, Teaching; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstruation Disturbances; Middle Aged; Nigeria; Norethindrone; Retrospective Studies; Risk Factors; Universities | 2009 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
Assessing menopausal status in women aged 40 - 49 using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraception.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone | 2011 |
Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract.
Topics: Blotting, Western; Cell Line; Cervix Uteri; Contraceptive Agents, Female; Cytokines; DNA Primers; Female; Gene Expression Regulation; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Real-Time Polymerase Chain Reaction; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Vagina | 2011 |
Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells.
Topics: Breast Neoplasms; Cell Membrane; Cell Proliferation; Female; Gene Expression; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Membrane Proteins; Norethindrone; Progesterone; Progesterone Congeners; Progestins; Receptors, Progesterone; Transfection | 2012 |
Ovarian cancer risk in postmenopausal women using estradiol-progestin therapy - a nationwide study.
Topics: Aged; Aged, 80 and over; Confidence Intervals; Estradiol; Estrogen Replacement Therapy; Female; Finland; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Cystic, Mucinous, and Serous; Norethindrone; Norethindrone Acetate; Ovarian Neoplasms; Postmenopause; Progestins; Risk Assessment; Time Factors | 2013 |
Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells.
Topics: Breast Neoplasms; Cell Proliferation; Clone Cells; Contraceptive Agents, Female; Drug Interactions; Estradiol; Estrogens; Female; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Membrane Proteins; Nandrolone; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Norethindrone; Osmolar Concentration; Progesterone; Progestins; Receptors, Progesterone; Recombinant Proteins | 2013 |
The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
Topics: Administration, Cutaneous; Age Factors; Aged; Case-Control Studies; Contraceptives, Oral, Hormonal; Desogestrel; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Netherlands; Norethindrone; Norethindrone Acetate; Odds Ratio; Postmenopause; Progestins; Risk Assessment; Risk Factors; Sex Factors; Transdermal Patch; Venous Thrombosis | 2013 |
Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy.
Topics: Animals; Antineoplastic Agents, Hormonal; Cell Line; Chlorocebus aethiops; Contraceptives, Oral, Synthetic; COS Cells; Gene Expression Regulation; Genes, Reporter; Humans; Luciferases; Medroxyprogesterone Acetate; Myocytes, Cardiac; Norethindrone; Norethindrone Acetate; Orosomucoid; Plasmids; Plasminogen Activator Inhibitor 1; Rats; Receptors, Mineralocorticoid; Response Elements; Signal Transduction; Transcription, Genetic; Transfection | 2013 |
Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy.
Topics: Animals; Breast Neoplasms; Cell Proliferation; Contraceptives, Oral, Synthetic; Drug Therapy, Combination; Estradiol; Estrogens; Female; Gene Expression; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Membrane Proteins; Mice; Mice, Nude; Norethindrone; Receptors, Progesterone; Transfection; Tumor Burden | 2013 |
The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor.
Topics: Amino Acid Sequence; Apoptosis; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cells, Cultured; Contraceptive Agents, Female; Dexamethasone; Gene Expression Regulation; Gene Products, vpr; HIV-1; Humans; Hydrocortisone; Medroxyprogesterone Acetate; Mifepristone; Molecular Sequence Data; Norethindrone; Norethindrone Acetate; Progesterone; Receptors, Estrogen; Receptors, Glucocorticoid; Signal Transduction | 2013 |
Next steps for research on hormonal contraception and HIV.
Topics: Contraception; Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic; Risk Assessment | 2013 |
Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1.
Topics: Breast Neoplasms; Cell Proliferation; Female; Formazans; Humans; Intercellular Signaling Peptides and Proteins; MCF-7 Cells; Medroxyprogesterone Acetate; Membrane Proteins; Norethindrone; Progesterone; Receptor Cross-Talk; Receptors, Progesterone; Tetrazolium Salts | 2013 |
The effectiveness of community based distribution of injectable contraceptives using community health extension workers in Gombe State, Northern Nigeria.
Topics: Adolescent; Adult; Community Health Workers; Condoms; Condoms, Female; Contraceptive Agents, Female; Delivery of Health Care; Feasibility Studies; Female; Health Promotion; Humans; Injections; Male; Maternal Mortality; Medroxyprogesterone Acetate; Middle Aged; Nigeria; Norethindrone; Socioeconomic Factors | 2013 |
Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.
Topics: Apoptosis; Breast Neoplasms; Caspase 3; Cell Proliferation; Cell Transformation, Neoplastic; Cyproterone Acetate; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Progesterone; Progestins; Receptors, Progesterone | 2013 |
Research on hormonal contraception and HIV.
Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic | 2014 |
Research on hormonal contraception and HIV.
Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic | 2014 |
Research on hormonal contraception and HIV.
Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic | 2014 |
Research on hormonal contraception and HIV - Authors' reply.
Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic | 2014 |
Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.
Topics: Adult; Cells, Cultured; Contraceptive Agents, Female; Cytokines; Delayed-Action Preparations; Dendritic Cells; Desogestrel; Female; HIV-1; Humans; Imidazoles; Immune Tolerance; Levonorgestrel; Lymphocyte Activation; Lymphocytes; Medroxyprogesterone Acetate; Norethindrone; Oligodeoxyribonucleotides; Progestins; Toll-Like Receptor 9; Toll-Like Receptors | 2014 |
Highlights from the 21st CROI.
Topics: Animals; Anti-HIV Agents; Child; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Hepatitis C; HIV Infections; Humans; Infant, Newborn; Male; Medication Adherence; Medroxyprogesterone Acetate; Norethindrone | 2014 |
The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor.
Topics: Cells, Cultured; Cervix Uteri; Contraceptive Agents; Epithelial Cells; Female; HeLa Cells; Humans; Injections; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Progesterone; Receptors, Glucocorticoid | 2014 |
A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A).
Topics: Androgens; Animals; Antineoplastic Agents, Hormonal; Blotting, Western; Chlorocebus aethiops; Contraceptives, Oral, Synthetic; COS Cells; Humans; Luciferases; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Progesterone; Progestins; Receptors, Androgen; Two-Hybrid System Techniques | 2014 |
Synthetic gestagens exert differential effects on arterial thrombosis and aortic gene expression in ovariectomized apolipoprotein E-deficient mice.
Topics: Animals; Aorta; Apolipoproteins E; Carotid Artery Thrombosis; Cells, Cultured; Contraceptive Agents, Female; Coronary Vessels; Endothelial Cells; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; Medroxyprogesterone Acetate; Mice, Knockout; Myocytes, Smooth Muscle; Norethindrone; Norethindrone Acetate; Oligonucleotide Array Sequence Analysis; Ovariectomy; Polymerase Chain Reaction | 2014 |
Clinicians' perceptions and provision of hormonal contraceptives for HIV-positive and at-risk women in Southern Africa: an original research article.
Topics: Adult; Aged; Attitude of Health Personnel; Contraceptives, Oral; Contraceptives, Postcoital, Hormonal; Directive Counseling; Evidence-Based Medicine; Family Planning Services; Female; Health Care Surveys; HIV Seropositivity; Humans; Injections, Intramuscular; Male; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Practice Patterns, Nurses'; Practice Patterns, Physicians'; Risk Factors; South Africa; Young Adult; Zimbabwe | 2014 |
Molecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative study.
Topics: Apoptosis; Breast Neoplasms; Dexamethasone; Estrogens; Female; Glucocorticoids; Hormone Replacement Therapy; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Mifepristone; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone Congeners; Receptors, Estrogen; Receptors, Glucocorticoid; Risk; Women's Health | 2014 |
Is expression of rat breast matrix components influenced by estrogen, progestins and tibolone?
Topics: Animals; Biomarkers; Breast; Cell Proliferation; Drug Combinations; Dydrogesterone; Estradiol; Estrogen Receptor Modulators; Estrogens; Extracellular Matrix; Female; Glucuronidase; Heparan Sulfate Proteoglycans; Immunohistochemistry; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Progestins; Proliferating Cell Nuclear Antigen; Random Allocation; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction | 2015 |
Effects of estradiol, progestogens, and of tibolone on breast proliferation and apoptosis.
Topics: Animals; Apoptosis; Breast; Cell Proliferation; Drug Combinations; Dydrogesterone; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Progestins; Random Allocation; Rats; Rats, Wistar | 2015 |
Injectable Progestin-Only Contraception is Associated With Increased Levels of Pro-Inflammatory Cytokines in the Female Genital Tract.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Cross-Sectional Studies; Cytokines; Female; Genitalia, Female; HIV Infections; Humans; Inflammation; Kenya; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Sexually Transmitted Diseases, Bacterial; South Africa; Vaginosis, Bacterial; Young Adult | 2015 |
DMPA use and HIV acquisition: time to switch to NET-EN?
Topics: Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Norethindrone | 2015 |
Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk.
Topics: Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Norethindrone | 2015 |
Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk.
Topics: Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Norethindrone | 2015 |
Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk - Authors' reply.
Topics: Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Norethindrone | 2015 |
Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk.
Topics: Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Norethindrone | 2015 |
Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk - Authors' reply.
Topics: Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Norethindrone | 2015 |
Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Topics: Administration, Cutaneous; Administration, Oral; Case-Control Studies; Estrogen Replacement Therapy; Estrogens; Female; Humans; Logistic Models; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Odds Ratio; Perimenopause; Postmenopause; Progestins; Risk Factors; Sweden; Vagina; Venous Thromboembolism | 2016 |
A comparison of progestins within three classes: Differential effects on learning and memory in the aging surgically menopausal rat.
Topics: Aging; Animals; Dose-Response Relationship, Drug; Estrogen Replacement Therapy; Learning; Levonorgestrel; Medroxyprogesterone Acetate; Memory; Models, Animal; Norethindrone; Norethindrone Acetate; Ovariectomy; Progestins; Psychological Tests; Random Allocation; Rats, Inbred F344 | 2017 |
Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells.
Topics: Cell Proliferation; Cell Survival; Cells, Cultured; Cellular Microenvironment; Cytokines; Endometriosis; Endometrium; Estrogens; Female; Humans; Immunosuppression Therapy; Inflammation; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progestins; Stromal Cells; Tumor Necrosis Factor-alpha | 2016 |
The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis.
Topics: Adult; Cytokines; Endometriosis; Endometrium; Female; Humans; Inflammation; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progestins; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Progesterone; Receptors, Steroid; Stromal Cells; Tumor Necrosis Factor-alpha | 2017 |
Impact of contraceptive initiation on vaginal microbiota.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; DNA, Bacterial; Drug Implants; Ethinyl Estradiol; Female; Gardnerella vaginalis; Humans; Intrauterine Devices, Copper; Lactobacillus crispatus; Lactobacillus gasseri; Levonorgestrel; Medroxyprogesterone Acetate; Megasphaera; Microbiota; Norethindrone; Polymerase Chain Reaction; Protective Factors; Risk Factors; Vagina; Vaginosis, Bacterial; Young Adult | 2018 |
Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels.
Topics: CD4 Antigens; CD4-CD8 Ratio; Cell Line; Female; HEK293 Cells; HIV-1; Humans; Leukocytes, Mononuclear; Medroxyprogesterone Acetate; Mifepristone; Norethindrone; Receptors, CCR5; Receptors, Glucocorticoid; RNA Interference; RNA, Small Interfering; T-Lymphocytes; Up-Regulation; Virus Replication | 2018 |
Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women.
Topics: Contraceptive Agents, Hormonal; Disease Susceptibility; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone | 2019 |
The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant concentrations.
Topics: Cervix Uteri; Contraceptive Agents, Hormonal; Dose-Response Relationship, Drug; Female; HEK293 Cells; HIV Infections; HIV-1; Humans; In Vitro Techniques; Medroxyprogesterone Acetate; Norethindrone; Receptors, CCR5; Risk Factors; RNA, Messenger; Virus Replication | 2019 |
Depot medroxyprogesterone acetate and norethisterone enanthate differentially impact T-cell responses and expression of immunosuppressive markers.
Topics: Adolescent; Adult; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Contraceptive Agents, Female; CTLA-4 Antigen; Female; Humans; Immunophenotyping; Lymphocyte Activation; Medroxyprogesterone Acetate; Norethindrone; Programmed Cell Death 1 Receptor; Young Adult | 2020 |
Norethisterone Enanthate Increases Mouse Susceptibility to Genital Infection with Herpes Simplex Virus Type 2 and HIV Type 1.
Topics: Animals; Contraceptive Agents, Female; Desmoglein 1; Disease Susceptibility; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mice, SCID; Mucous Membrane; Norethindrone; Permeability; Vagina | 2020 |
Medroxyprogesterone acetate inhibits wound closure of human endometrial epithelial cells and stromal fibroblasts in vitro.
Topics: Adult; Cells, Cultured; Contraceptive Agents; Endometrium; Epithelial Cells; Female; Fibroblasts; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Progesterone; Wound Healing | 2021 |
Differential off-target glucocorticoid activity of progestins used in endocrine therapy.
Topics: Animals; Chlorocebus aethiops; COS Cells; Glucocorticoids; Interleukin-6; Leukocytes, Mononuclear; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Progestins; Receptors, Glucocorticoid | 2022 |
Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age.
Topics: Adult; Case-Control Studies; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Progesterone; Progestins; Venous Thromboembolism | 2022 |
Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha.
Topics: Breast Neoplasms; Cathepsin D; Estradiol; Estrogen Receptor alpha; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Progesterone; Progesterone Congeners; Progestins; Receptors, Estrogen; Receptors, Progesterone; Up-Regulation | 2022 |